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Trista M. Berry, B.S. 
Advisory Professor: Peter J. Christie, Ph.D. 
 
Many bacteria use Type IV Secretion Systems (T4SSs) to aid in pathogenesis by 
translocating virulence factors across the cell envelope and into eukaryotic cells.  These 
systems are structurally and functionally diverse, but are often compared to the archetypal 
VirB/VirD4 T4SS of Agrobacterium tumefaciens. This system is composed of the VirD4 type 
IV coupling protein (T4CP) and 11 VirB subunits (VirB1-11) that assemble as the secretion 
channel and an extracellular pilus. The T4CP is an inner membrane ATPase that interacts 
with T4SS substrates and the secretion channel, and is thought to link substrates with the 
secretion channel and possibly energize transfer through the channel lumen. In this thesis, I 
sought to adapt T4SSs in the surrogate hosts A. tumefaciens and Escherichia coli for use in 
identification of novel T4SS effector proteins from genetically-intractable Rickettsial species.  
I first constructed chimeric T4SSs in A. tumefaciens by substituting native VirD4 with 
Rickettsial VirD4 homologs.  However, I was unable to demonstrate transfer of the 
promiscuous IncQ plasmid pML122 or known A. tumefaciens effector proteins. I next tested 
the E. coli pKM101-encoded T4SS, which is known to transfer DNA substrates, for the 
capacity to deliver heterologous protein substrates to E. coli recipients.  Using the Cre-
recombinase reporter assay for translocation (CRAfT), I showed that pKM101 translocates 
effector proteins from A. tumefaciens and two Rickettsial species, Anaplasma 
phagocytophilum and Wolbachia pipientis. I next created chimeric T4CPs by joining the 
transmembrane domain (TMD) of pKM101-encoded TraJ with the soluble domains (SDs) of 
VirD4 homologs from A. tumefaciens and the Rickettsial species.  I showed that all of these 
chimeric systems translocate protein substrates, although less efficiently than the native 
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pKM101 T4SS.  Finally, I demonstrated that a variable C-terminal extension (CTE) that is 
present on the A. tumefaciens and Rickettsial T4CPs plays a modulatory role for secretion 
of different protein substrates.  My findings showed for the first time that a T4SS encoded by 
an E. coli conjugative plasmid is capable of translocating a variety of protein substrates from 
phylogenetically diverse alphaproteobacterial species, including A. tumefaciens, A. 
phagocytophilum, and W. pipientis.   
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Introduction 
 
Type 4 secretion systems are diverse and multi-functional 
Many Gram-negative and Gram-positive bacteria use Type IV secretion systems 
(T4SSs) to translocate virulence factors across the cell membrane(s) and into target cells to 
aid in pathogenesis [1-3].  T4SSs are typically separated into three main subfamilies: (a) 
conjugation systems that translocate DNA substrates between cells in a contact dependent 
manner; (b) effector translocation systems that deliver protein substrates directly into target 
cells; and (c) DNA uptake and release systems, known to move DNA to or from the 
extracellular environment [1, 3, 4].  However, functionality of a specific system is not always 
exclusive to one subfamily.  For instance, Agrobacterium tumefaciens, of the class 
Alphaproteobacteria, uses the prototypical VirB/VirD4 conjugative T4SS to deliver both 
transfer DNA (T-DNA) and protein substrates (e.g., VirE2) into plant cells [4, 5] thereby 
making it both a conjugative system and an effector translocation system.  This T4SS-
mediated transfer of both T-DNA and protein effectors from A. tumefaciens causes the 
formation of tumors on the plant, known as crown gall disease [3, 4].    
T4SSs are diverse structurally and in the types of substrates they secrete.  In A. 
tumefaciens, the virB operon encodes all the subunits for assembly of the T4SS, including 
the channel subunits VirB6-VirB10; the pilus subunits VirB2 and VirB5; and three ATPases 
VirB4, VirB11 and VirD4 (Figure 1.1) [6].  Most T4SSs employed by Gram-negative bacteria 
are composed of homologs of the VirB and VirD4 subunits, but there are many evolutionary 
adaptations as well, resulting in T4SSs composed of additional subunits of unrelated 
ancestries to the VirB/VirD4 subunits [7].  In Gram-positive bacteria, the T4SSs appear to be 
minimized in the sense that they are composed principally of homologs or orthologs of A. 
tumefaciens VirD4, VirB4, VirB1, VirB3, VirB6, and VirB8 [2].   
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Figure 1.1  DNA transfer through the A. tumefaciens VirB/VirD4 Type IV Secretion 
System.  
The schematic shows the subcellular localizations of the VirD4 substrate receptor or T4CP 
and two other ATPases VirB4 and VirB11, the channel subunits VirB6-VirB10, and the pilus 
subunits VirB2 and VirB5.  Also shown is the path of the DNA substrate, indicating a primary 
interaction with the VirD4 coupling protein, followed by shuttling to the VirB11 ATPase, prior 
to entering the secretion channel.  OM, outer membrane, IM, inner membrane. 
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VirD4: The substrate receptor 
 In 2004, our lab used an assay termed transfer-DNA immunoprecipitation (TrIP) to 
experimentally describe the pathway of substrate secretion in A. tumefaciens [8].  Briefly, by 
formaldehyde (FA) cross-linking proteins to the DNA substrate, followed by 
immunoprecipitation of the Vir proteins, we identified T4SS subunits that formed an FA-
crosslinkable contact with DNA as it exited the cell by PCR amplification.  In order to 
describe the pathway of substrate secretion, mutants lacking single virB or virD4 genes 
were analyzed by TrIP; such mutations blocked DNA transfer at specific stages during 
translocation. Using this methodology, it was established that VirD4 initially recruits the 
relaxasome/T-DNA complex to the T4SS apparatus (Figure 1.1).  From here, the substrate 
is transferred to the VirB11 ATPase, then VirB6/B8 at the inner membrane, and finally 
through a channel composed of the VirB2 and VirB9 subunits for passage through the 
periplasm and outer membrane. 
Much of the work in this thesis is focused on the type IV coupling protein (T4CP) 
from A. tumefaciens, VirD4, and its homologs, including TraJ from the IncN plasmid pKM101 
and the VirD4-like proteins from some Rickettsial species.  In order to delineate the different 
VirD4-like proteins, I will indicate the species of origin as a subscript (VirD4At, A. 
tumefaciens; VirD4Ap, Anaplasma phagocytophilum; VirD4Wp, Wolbachia pipientis; and 
VirD4Rr, Rickettsia rickettsii). VirD4 is an inner membrane ATPase that interacts with T4SS 
substrates and is thought to energize the transfer of the substrate through the lumen of the 
channel created by the other Vir proteins [1]. VirD4 is termed a coupling protein (or T4CP) 
because it links the relaxosome, formed by the DNA transfer and replication (Dtr) proteins, 
with the translocation channel and pilus, formed by the mating pair formation (Mpf) proteins 
[1, 9].  It is suggested that the T4CP interaction with the Mpf proteins occurs via 
transmembrane domains at the inner membrane, while recruitment and binding of the 
relaxosome and associated Dtr proteins occurs via one or more domains comprising the 
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soluble portion of the T4CP [9, 10].  VirD4-like coupling proteins are associated with most 
T4SSs; those of interest to my thesis project include VirD4At, the Rickettsial T4CPs 
mentioned above, and T4CPs encoded by E. coli conjugative plasmids including TrwBR388 
[11], TraDF [12], and TraJpKM101 [10].   
T4CPs generally consist of an N-terminal transmembrane domain (TMD), a 
nucleotide binding domain (NBD), the all-alpha domain (AAD), and often a C-terminal 
extension (CTE) (Figure 1.2) [11].  The T4CP from E. coli plasmid R388, TrwB, is the 
structural paradigm for all T4CPs.  A soluble variant of TrwB has been crystallized as a 
homohexamer with a central channel of approximately 20 Å in diameter [11, 13].  The 
overall structure of TrwB, is that of an F1-FO ATPase-like ball-stem with the TMD having an 
integral role in hexamer formation in addition to anchoring the T4CP within the inner 
membrane [11, 13].  The TMD of the TrwB monomer consists of at least two transmembrane 
helices that span the inner membrane [1], and is thought to be responsible for interaction of 
the T4CP with the channel subunits [1, 11].  
The NBD includes Walker A and B nucleoside triphosphate binding site motifs 
characteristic of ATPases, and shares both structural and sequence similarities with E. coli 
FtsK and Bacillus subtilis SpoIIIE [14]. FtsK and SpoIIIE are hexameric double-stranded (ds) 
DNA translocases that bind and translocate chromosomal DNA during cell division or 
sporulation.  This movement of DNA is thought to occur through the central channel of the 
hexameric ring and has led to proposals that the T4CPs may translocate DNA substrates 
across the inner membrane in a similar manner [14, 15]. The AAD is a seven-helix bundle 
positioned at the cytoplasmic end of the T4CP hexamer and bears structural similarity to the 
XerD site-specific recombinase [11, 16]. Both its relative location in the T4CP and its 
structural homology to a DNA-binding protein has lead to the suggestion that the AAD 
participates in substrate recognition and delivery to the transfer channel.  
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The specific interface for T4CP-substrate interaction has yet to be determined.  
While the AAD might be involved in substrate docking, it is noteworthy that the AAD’s of 
VirD4 homologs are generally closely related among different species of the 
alphaproteobacteria, e.g., A. tumefaciens and Rickettsial spp. (Figure 1.3) [1], suggesting 
that this domain alone does not mediate substrate specificity to cognate T4SSs.  To better 
define the domains contributing to T4SS substrate specificity, we constructed various T4CP 
domain deletions and substitutions. Specifically, a postdoctoral fellow in the Christie lab, Dr. 
N. Whitaker, determined that deletion of the AAD of pKM101-encoded TraJ abolished 
plasmid transfer, indicating that this AAD may have a role in DNA substrate interactions 
(See Chapter 5).  Additionally, I determined that the C-terminal extension (CTE), which is 
carried by a subset of the T4CPs, is highly variable (Figure 1.4) [1].  In Chapters 3 and 5, I 
present data indicating that deletion of the CTE’s from T4CPs from A. tumefaciens 
Rickettsial homologs alters translocation efficiencies of some protein substrates. 
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Figure 1.2  VirD4 coupling protein (T4CP) domain structure 
A. Schematic representation of the domain organization of A. tumefaciens VirD4. 
Numbers depict residues marking the domain boundaries along the length of the 
protein. TMD, transmembrane domain; AAD, all alpha domain; NBD, nucleotide 
binding domain; CTE, C-terminal extension.  
B. Topology schematic of TrwB modified from Gomis-Ruth, et al. 2002.  
This figure was modified to identify domains, but TrwB lacks a C-terminal extension 
found in VirD4 and other T4CPs.  Permission for use granted by the American 
Society for Biochemistry and Molecular Biology.  
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Figure 1.3  Sequence alignment of the all-alpha domains (AAD’s) of VirD4 homologs  
AAD sequence alignment from different alphaproteobacteria under study in this thesis. 
VirD4At, A.tumefaciens residues 201-346; VirD4Ap, A. phagocytophilum residues 218-351; 
VirD4Wp, Wolbachia spp. residues 218-352; VirD4Rr, R. rickettsii residues 215-348.  
Alignment shows high sequence conservation amongst the AAD’s, especially those of the 
Rickettsial homologs.  Red residues, high consensus (90%); blue residues, low consensus 
(50%). 
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Figure 1.4  Sequence alignment of the C-terminal extensions (CTE’s) of VirD4 
homologs  
CTE sequence alignment from different alphaproteobacteria under study in this thesis. 
VirD4At, A.tumefaciens residues 552-656; VirD4Ap, A. phagocytophilum residues 573-740; 
VirD4Wp, Wolbachia spp. residues 573-676; VirD4Rr, R. rickettsii residues 570-591.  
Alignment shows almost no sequence conservation, high variability in domain length, and 
over-representation of acidic residues. Blue residues, low consensus (50%). 
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Chimeric T4SS as a study tool 
A. tumefaciens is phylogenetically closely related to Rickettsial species, including 
those of Anaplasma, Wolbachia, and Rickettsia genera [1, 7, 17].  In Rickettsiales, much of 
the A. tumefaciens VirB/VirD4 T4SS is conserved, including many of the VirB1-VirB11 
channel subunit proteins and the VirD4 T4CP [1, 17].  These Rickettsial T4SSs translocate 
effector proteins into host cells to cause a variety of animal and human diseases, making 
the study of these organisms medically important [1].  However, functional characterization 
of Rickettsial T4SSs and the effectors translocated during infection have been hindered by 
difficulties in cultivation of Rickettsial species in the lab and their genetic intractability. 
Various approaches have been taken to identify novel effectors whose translocation 
contributes to the virulence of species that are difficult to genetically manipulate, e.g., 
intracellular pathogens [18, 19]. Production of candidate effectors in surrogate hosts 
followed by tests for T4SS translocation has supplied evidence for translocation of candidate 
effectors of intracellular bacteria, as summarized by Alvarez-Martinez and Christie [1].  For 
example, A. phagocytophilum AnkA was identified as a possible effector by demonstrating 
its translocation through the A. tumefaciens VirB/D4 T4SS [20]. In this case, AnkA was 
fused to the Cre recombinase and the fusion protein was shown to translocate through the 
A. tumefaciens VirB/VirD4 T4SS into plant cells.  Translocation was detected by engineering 
plant cells to carry a GFP reporter gene that is interrupted by a DNA segment flanked by two 
lox sites.  Translocation of Cre-AnkA to plants resulted in Cre-mediated excision of the lox 
cassette, allowing production of GFP in the plant.  Similar surrogate systems have been 
used to identify possible T4SS substrates of Coxiella burnetii [21], and Anaplasma 
marginale [22].   
Others have attempted using chimeric T4SSs to demonstrate transfer of non-
cognate substrates [9, 23].  These chimeric T4SSs produce a heterologous substrate 
receptor along with the native VirB channel complex and have been shown to retain the 
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capacity to translocate at least some substrates [1].  For example, a chimeric T4SS in 
plasmid R388, producing the T4CP from RP4, was shown to functionally complement for 
transfer of the mobilizable plasmid RSF1010 [23].  In this case, the authors found that the 
native T4CP, TrwB, could complement an R388 trwB- strain of Escherichia coli for 
translocation of the plasmid RSF1010.  Additionally, the T4CP from RP4, TraG, was able to 
complement the same strain at wild-type levels for RSF1010 transfer, but not for R388 self-
transfer.  This demonstrated that such chimeric T4SSs are limited in their functionality.  
 
Significance 
 The current approaches being used to identify novel effectors using native hosts or 
surrogate systems are often complicated by difficulties in genetic manipulation of the host 
species or inefficiencies in effector recognition by surrogate systems [20-22]. The 
overarching aim of this thesis project was to determine the capacity of two model and easily 
manipulated T4SSs, one from A. tumefaciens and the second from E. coli, to serve as 
surrogate hosts for translocation of candidate T4SS effectors of Rickettsial spp.  A second 
goal was to define the importance of the VirD4 CTE’s for substrate transfer.  Although the 
work presented utilizes known or previously identified substrates, the methods used should 
allow for high-throughput screens to identify novel substrates. 
 In chapter 3, I present results of studies exploring the capacity of genes encoding 
Rickettsial VirD4-like proteins to complement an A. tumefaciens virD4 null mutation for 
transfer of A. tumefaciens effectors and a mobilizable IncQ plasmid, pML122.  The 
Rickettsial virD4 genes do not complement for translocation of A. tumefaciens effectors, but 
their expression in an otherwise wild-type background confers dominant negative 
phenotypes suggestive of disruptive interactions with other T4SS components.  I also 
defined the importance of VirD4’s CTE for substrate transfer in A. tumefaciens.  
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 In chapter 4, I explore use of the Tra T4SS encoded by E.coli plasmid pKM101 as a 
surrogate system for translocating substrates shown or postulated to be translocated 
through A. tumefaciens or Rickettsial spp. T4SSs. I collaborated with another student, Jay 
Gordon, to create a nonpolar traJ deletion mutant using recombineering.  Using this deletion 
mutant, I demonstrated that while genes encoding Rickettsial VirD4 homologs do not 
complement the ΔtraJ mutation for pKM101 self-transfer or for transfer of IncQ, they do 
complement for transfer of some protein substrates.  Additionally, I was able to establish the 
ability of the wild-type pKM101 T4SS to translocate non-cognate substrates.  These 
discoveries are highly important, as this is the first demonstration of protein transfer in the 
pKM101 system.   
 Finally, in chapter 5, I explore the functionality of chimeric T4CPs in mediating 
substrate transfer through the pKM101 transfer system.  These chimeric T4CPs are 
composed of the TMD from TraJ and the soluble domain (SD) of the VirD4 homologs.  The 
hypothesis under investigation was that TraJ’s TMD would mediate a productive interaction 
with pKM101’s T4SS channel, and the SD would recruit heterologous substrates for delivery 
through the channel.  Since the native pKM101 system was found to translocate 
heterologous protein substrates, the goal of this line of work was to optimize translocation 
efficiencies.  I determined that some chimeric VirD4 proteins support protein transfer, and I 
explored the roles of the CTE and AAD in mediating substrate transfer using the chimeric 
systems.  
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Chapter 2.  Materials and Methods 
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Bacterial strains and growth/induction conditions  
 All strains used are listed in Table 2.1.  A. tumefaciens A348 and E. coli DH5α and 
MS411 served as the wild-type strains for these studies [24-26].  Strain Mx355, a derivative 
of A348 with a transposon insertion in virD4 [27], served as a virD4 null mutant.  Plasmid 
constructions were carried out with E. coli DH5α, as described below.  Growth conditions of 
A. tumefaciens cells have been previously described [28].  Briefly, strains are grown on 
MG/L plates (Luria Bertani (LB) media supplemented with mannitol and glutamate) for 2 
days at 28 °C [28, 29].  Colonies were inoculated into MG/L broth and grown overnight at 
room temperature while shaking.  Appropriate antibiotics were added for maintenance of 
plasmids in the following concentrations:  carbenicillin (100 µg/ml), kanamycin (100 µg/ml), 
gentamicin (100 µg/ml), spectinomycin (200-400 µg/ml) [24, 30, 31].  For induction of vir 
genes, cultures of A. tumefaciens strains were grown overnight with antibiotic selection, and 
then 1 ml of the culture was pelleted and resuspended in ABIM (minimal media 
supplemented with the inducer, acetosyringone (100 µM)) [32].  Cells were incubated for 16-
18 hours with shaking at room temperature. 
 E. coli strains were grown as previously described [25, 33].  Briefly, strains were 
grown on LB plates overnight at 37 °C.  Colonies were inoculated into LB broth and grown 
overnight at 37 °C while shaking.  Appropriate antibiotics were added in the following 
concentrations unless noted otherwise: carbenicillin (100 µg/ml), kanamycin (50 µg/ml), 
gentamicin (20 µg/ml), spectinomycin (100 µg/ml), tetracycline (20 µg/ml), chloramphenicol 
(20 µg/ml) [24, 34].  For arabinose induction of genes encoding Cre-effector fusion proteins, 
50 µl of overnight culture was inoculated into 5 ml LB broth and grown to mid-log phase 
(OD600 ~0.4-0.6). Optical density readings were taken on a Beckman DU 530 UV/Vis 
spectrophotometer.  Cells were induced by addition of 0.2% arabinose and incubation with 
shaking for 2-4 hrs.  Cultures were normalized by OD600 and 1 ml of cells was used for 
protein analysis.   
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Table 2.1  Bacterial strains and plasmids 
 
Strain or plasmid Relevant characteristic(s) Source 
E. coli strains   
    DH5α F- φ80lacZΔM15 Δ(lacZYA-argF)U169 recA1 endA1 
hsdR17(rk-, mk+) phoA supE44 thi-1 gyrA96 relA1 λ- 
Gibco-BRL/ 
Invitrogen 
WM1650 CAG18477; Tet linked to priA(+) [35] 
MS411   ilvG rfb-50 thi [33] 
CSH26Cm::LTL Tetr, CSH26 galK::cat::loxP-Tet-loxP; Camr after Cre 
mediated excision at loxP sites 
[33] 
A. tumefaciens 
strains 
  
    A348 A. tumefaciens containing octopine-type Ti plasmid 
pTiA6NC 
[26] 
  A348-Spcr Spcr; derivative of A348 [36] 
Mx355 A348 derivative virD4::Tn3HoHo1 [27] 
Vector plasmids   
pBSKS Crbr; cloning vector Stratagene 
pBSK Crbr; cloning vector Stratagene 
pBSIIKS+ Crbr; cloning vector Stratagene 
 pBSIIKS+NdeI Crbr; cloning vector containing NdeI restriction site at the 
translational start site of lacZ 
[37] 
pBBR1MCS2-GenR Genr; broad-host-range cloning vector [38] 
   pXZ151 Kanr; broad-host-range IncP derivative of pSW172 
encoding a Kanr cassette 
[39] 
pML122ΔKm     Genr; mobilizable IncQ derivative (RSF1010) [40] 
pUC4K Kanr; source of cassette conferring Kanr Amersham 
pHP45Ω Spcr; source of cassette conferring Spcr [41] 
pBAD24 Crbr; pBR322/ColE1 expression vector inducible with 
arabinose 
[42] 
pBAD24-Kanr Kanr, Crbs; gene conferring Kanr from pUC4K inserted in 
the Crbr gene of pBAD24 
This Study 
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pKM101 Crbr; broad-host-range IncN plasmid derived from R46 [43] 
pKM101-Spcr Spcr, Crbs; pKM101 with the cassette conferring Spcr 
from pHP45Ω inserted into the Crbr gene at EcoRI 
This Study 
pKM101ΔtraJ Spcr, Crbs;  pKM101-Spcr containing a clean deletion of 
traJ 
This Study 
pBAD33 Camr;  pACYC184/p15A expression plasmid inducible 
with arabinose 
[42] 
pBAD33-Cre Camr;  pBAD33 expressing Cre recombinase from an 
arabinose inducible promoter 
This Study 
A. tumefaciens 
Expression Plasmids 
  
pPC914KS+ Crbr; pBSIIKS+ derivative expressing PvirB-virB1; 
expression vector when substituting other genes for virB1 
[44] 
pXZ27 Crbr; pBSIIKS+NdeI expressing PvirB-virE2; expression 
vector when substituting other genes for virE2 
[39] 
pZZ11 Crbr; pPC914KS+ expressing PvirB-GST [37] 
pKA9 Crbr; pBSIIKS+ expressing PvirB-virD4At [45] 
pTB7 Crbr; pPC914KS+ expressing PvirB-virD4Ap  This Study 
pTB12 Crbr; pPC914KS+ expressing PvirB-virD4Wp This Study 
pTB19 Crbr, Kanr; pTB12 ligated to pXZ151 for expression in A. 
tumefaciens 
This Study 
pTB20 Crbr, Kanr; pTB7 ligated to pXZ151 for expression in A. 
tumefaciens 
This Study 
pTB22 Crbr, Kanr; pKA9 ligated to pXZ151 for expression in A. 
tumefaciens 
This Study 
pTB37 Crbr; pXZ27 expressing PvirB-virD4AtΔ553 This Study 
pTB46 Crbr, Kanr; pTB37 ligated to pXZ151 for expression in A. 
tumefaciens 
This Study 
E. coli Expression 
Plasmids 
  
pTB25 Kanr; pBAD24-Kanr expressing virD4Wp from pTB12 This Study 
pTB26 Kanr; pBAD24-Kanr expressing traJ from pKM101 This Study 
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pTB47 Kanr; pBAD24-Kanr expressing virD4At from pKA9 This Study 
pTB48 Kanr; pBAD24-Kanr expressing virD4Ap from pTB7 This Study 
pTB49 Crbr; pBAD24 expressing virD4Rr This Study 
pNW5 Crbr; pBSIIKS+NdeI expressing virD4At from pKA9 This Study 
pNW7 Crbr; traJΔAAD, containing a deletion of the all-alpha 
domain, cloned into pBAD24 
This Study 
Chimeric virD4 
plasmids 
  
pTB38 Kanr; traJ::virD4Ap cloned into pMK-RQ as provided by 
Invitrogen 
This Study, 
Invitrogen 
pTB39 Crbr; pBAD24 expressing traJ::virD4Ap from pTB38 This Study 
pTB50 Crbr; pBAD24 expressing traJ::virD4ApΔ574 This Study 
pTB51 Crbr; pBAD24 expressing traJ::virD4Wp This Study 
pTB52 Crbr; pBAD24 expressing traJ::virD4WpΔ574 This Study 
pNW1 Crbr; transmembrane domain of traJ cloned into pBSIIKS+ This Study 
pNW2 Crbr; soluble domain of virD4At cloned into pNW1 This Study 
pNW4 Crbr; virD4AtΔ553 containing a C-terminal deletion at 
residue 553 cloned into pNW1 generating 
traJ::virD4AtΔ553 
This Study 
pNW6 Crbr; virD4At SDΔAAD containing a deletion of the all-
alpha domain cloned into pNW1 generating 
traJ::virD4AtΔAAD 
This Study 
pNW10 Crbr; traJ::virD4At with the AAD of traJ cloned into 
pBSIIKS+ 
This Study 
pNW11 Crbr; traJ with the AAD of virD4At cloned into pBAD24 This Study 
Effector Plasmids   
pTB30 Crbr; putative Anaplasma effector Aph_0111 cloned into 
pBSK 
This Study; 
J. Carlyon1 
pTB40 Camr; ats-1 cloned into pBAD33-Cre This Study; 
J.Carlyon1 
pTB41 Camr; Aph_0111 from pTB30 subcloned into pBAD33-
Cre 
This Study 
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pTB42 Camr; ats-1 CTD cloned into pBAD33-Cre This Study; 
J.Carlyon1 
pTB43 Camr; putative Wolbachia effector WD0636 cloned into 
pBAD33-Cre 
This Study; 
I. Newton2 
pTB44 Camr; putative Wolbachia effector WD0811 cloned into 
pBAD33-Cre 
This Study; 
I. Newton2 
pTB45 Camr; putative Wolbachia effector WD0830 cloned into 
pBAD33-Cre 
This Study; 
I. Newton2 
pTB53 Camr; virE3 cloned into pBAD33-Cre after PCR 
amplificantion of the Ti plasmid 
This Study 
pTB54 Camr; virF cloned into pBAD33-Cre after PCR 
amplification of the Ti plasmid 
This Study 
pTB55 Camr; virE2 from pXZ27 subcloned into pBAD33-Cre This Study 
 
1 Anaplamsa phagocytophilum genomic DNA provided by Jason Carlyon at Virginia 
Commonwealth University; 2 Wolbachia pipientis putative effector genes provided by Irene 
Newton at Indiana University, all were received in pENTR-D/TOPO vectors and PCR 
amplified for cloning. 
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Plasmid constructions 
 Plasmids used in this study are listed in Table 2.1 and primers used for PCR are 
listed in Table 2.2.  The vector plasmid pBAD24-Kanr was made by isolation of a gene 
conferring kanamycin resistance as a HincII fragment from pUC4K and insertion into the 
single ScaI restriction site within pBAD24 [42].  The conjugative plasmid pKM101-Spcr was 
made by isolation of a gene conferring spectinomycin resistance as an EcoRI fragment from 
pHP45Ω and insertion into similarly digested pKM101.  The resulting plasmid is Spcr and 
Crbs and retains all of its conjugative abilities.   
Plasmid pTB7 expresses the A. phagocytophilum virD4 homolog (virD4Ap) from the 
PvirB promoter.  virD4Ap was PCR amplified from pBT-virD4 [46] using the primers 5’-
AGTCGTCATATGCATAGTTCCAATCAT-3’ and 5’-
TTAGTGCTCGAGCTACTTTAGTCTTCC-3’.  The PCR product was digested with NdeI and 
XhoI and ligated to similarly digested ColE1 plasmid, pPC914KS+ [44].  Plasmid pTB12 
expresses the W. pipientis virD4 homolog (virD4Wp) from the PvirB promoter.  virD4Wp was 
PCR amplified using pCR-VirD4 as a template (provided by Katrin Gentil; Bonn, Germany) 
and primers 5’-TAAGCGATCACCATGGGTCATAGC-3’ and 5’-
GCTAGCTCGGGTACCTTACTTTCC-3’.  The PCR product was digested with NcoI and 
KpnI, and the resulting fragment was ligated into similarly digested pPC914KS+.  Plasmid 
pTB26 expresses the pKM101 virD4 ortholog (traJ) from the PBAD promoter.  traJ was PCR 
amplified using pKM101 as a template and primers 5’-
CAGTAGCCATGGACGATAGAGAAAGA-3’ and 5’-
ACAATTGGTACCTCAGATCTCCCTCAG-3’. The PCR product was digested with NcoI and 
KpnI, and the resulting fragment was ligated into similarly digested pBAD24-Kanr.  Plasmid 
pTB37 expresses virD4AtΔ553, which encodes A. tumefaciens VirD4 deleted of its C-
terminal 104 residues, from the PvirB promoter.  virD4AtΔ553 was PCR amplified using 
plasmid pKA9 [45] as a template and primers 5’-CGGTGAACATATGAATTCCAGCAA-3’ 
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and 5’-CTATTAGGTACCTCAGGGCTCAGGCAGAGA-3’.  The PCR product was digested 
with NdeI and KpnI, and the resulting fragment was ligated into similarly digested pXZ27 
[39], replacing the virE2 gene.  Plasmid pTB49 expresses the R. rickettsii virD4 homolog 
(virD4Rr) from the PBAD promoter.  virD4Rr was PCR amplified from genomic DNA sent from 
the Betsy Kleba lab using the primers 5’-GTGCCATGGCATAAGATACTTAAAG-3’ and 5’-
ATTCTCGAGTTACTCATTATTTTCCGG-3’.  The PCR product was digested with NcoI and 
XhoI, and the resulting fragment was ligated into pBAD24 digested with NcoI and SalI.  All 
plasmid constructs were confirmed by PCR, digestion analysis, and sequencing.  
A postdoctoral fellow in the Christie lab, Dr. N. Whitaker, created the following 
plasmid constructs.  Plasmid pNW5 expresses virD4At from the Plac promoter.  virD4At was 
PCR amplified using plasmid pKA9 as a template and primers 5’-
CGGTGAACATATGAATTCCAGCAA-3’ and 5’-
GTTCTCGAGTCATTTCGCAGGCTGTGCCG-3’ (Table 2.2).  The PCR product was 
digested with NdeI and XhoI and the resulting fragment was ligated into similarly digested 
pBSIIKS+NdeI [37]. Plasmid pNW7 expresses traJΔAAD from the PBAD promoter.  The AAD 
of TraJ (amino acids 186-298) was deleted using overlapping PCR [47, 48].  The gene 
sequences encoding residues 1-185 and 299-509 of traJ were PCR amplified using the 
primers 5’-CCATGGACGATAGAGAAAGAGGC-3’ and 5’-
GCAGGGAAAAATTTTCAGTGCGTTTATCATAGG-3’, and 5’-
TGATAAACGCACTGAAAATTTTCCTGCGTGACTGGC-3’ and 5’-
GGTACCTCAGATCTCCCTCAGTTCAA-3’, respectively.  The two PCR products were used 
as templates for overlapping PCR with outside primers (5’-
CCATGGACGATAGAGAAAGAGGC-3’ and 5’-GGTACCTCAGATCTCCCTCAGTTCAA-3’).  
The final PCR product was digested with NcoI and KpnI, and the resulting fragment was 
ligated into similarly digested pBAD24.  Plasmids were confirmed with sequencing 
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Table 2.2  Oligonucleotides used for T4CP and effector constructions 
 
VirD4 Homologs 
VirD4Ap 5’-AGTCGTCATATG1CATAGTTCCAATCAT-3’ 
5’-TTAGTGCTCGAG2CTACTTTAGTCTTCC-3’ 
VirD4Wp 5’-TAAGCGATCACCATGG3GTCATAGC-3’ 
5’-GCTAGCTCGGGTACC4TTACTTTCC-3’ 
VirD4Rr 5’-GTGCCATGG3CATAAGATACTTAAAG-3’ 
5’-ATTCTCGAG2TTACTCATTATTTTCCGG-3’ 
VirD4AtΔ553  5’-CGGTGAACATATG1AATTCCAGCAA-3’ 
5’-CTATTAGGTACC4TCAGGGCTCAGGCAGAGA-3’ 
VirD4ApΔ574 Reverse 5’-AGTTCTCGAG2CTACTTTTCAGGATCGTACGG-3’ 
VirD4At Reverse (pNW5) 5’-GTTCTCGAG2TCATTTCGCAGGCTGTGCCG-3’ 
TraJ 5’-CAGTAGCCATGG3ACGATAGAGAAAGA-3’ 
5’-ACAATTGGTACC4TCAGATCTCCCTCAG-3’ 
TraJΔAAD (1-185) 5’-CCATGG3ACGATAGAGAAAGAGGC-3’ 
5’-GCAGGGAAAAATTTTCAGTGCGTTTATCATAGG-3’  
TraJΔAAD (299-509) 5’-TGATAAACGCACTGAAAATTTTCCTGCGTGACTGGC-3’ 
5’-GGTACC4TCAGATCTCCCTCAGTTCAA-3’ 
Chimeric VirD4’s 
TraJ::VirD4ApΔ574* 5’-TTCCGGGTCATAAGGTTCTTGG-3’ 
5’-TAAATTCGTGGTGGTGTTGAAGG-3’ 
TraJ::VirD4Wp** 5’-GATTATTCTTTCTCTATAAATGATAAAAGCGATCAGACCG 
CCAAC-3’ 
5’-GCTTTTATCATTTATAGAGAAAGAATAATCGAGTGGCGG 
CC-3’ 
5’-GTATCTCGAG2TTACTTTCCATTACTTTTTGGTTTATCACC 
ATCATCTTCATC-3’ 
TraJ::VirD4WpΔ574** 5’-CTATCTCGAG2TTATGGGTCATATGGCTCCTGTGTAGGT 
ACATAAGTC-3’ 
TraJ TMD (1-75) 5’-CATACCATGG3ACGATAGAGAAAGAGGCTTAGCATTTTT 
ATTTG-3’ 
5’-GTATCTCGAG2TATATATCATATG1ATAAATGATAAAAGCG 
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ATCAGACCGCCAAC-3’  
VirD4At SDΔ553  5’- CATATATATACATATG1AATCAGAAGCATCACGGGACGG-3’ 
5’- GTTCTCGAG2TCAAGGGTGCGGGCTCAGGCAG-3’ 
TraJ::VirD4At (1-190) 5’-TCATGA6ATGGACGATAGAGAAAGAGG-3’ 
5’-GAAAAACACCCAGCCAGAATCTAGGGGGGAAAACTTGA 
AAAC-3’ 
TraJ AAD (186-298) 5’-TCCCCCCTAGATTCTGGCTGGGTGTTTTTCAATGAAA-3’ 
5’-AATGCAGGTCTTCTTACCTTCCGGCATTTTCAAATGTG-3’ 
VirD4At (347-656) 
 
5’-AAAATGCCGGAAGGTAAGAAGACCTGCATTTATCTTTGT 
GTCAGTC-3’ 
5’-CTCGAG2TCATTTCGCAGGCTGGTGCCGGTGC-3’ 
TraJ (1-185)*** 5’- ATGAGTCTTCCGCTCTTCAGTGCGTTTATCATAGGCG-3’ 
VirD4At AAD (132-346) 
 
5’-GATAAACGCACTGAAGAGCGGAAGACTCATTGTTACAA 
TCC-3’  
5’- CACGCAGGGAAAAATTCCTCCGGAGATCGTAAACGGAA-3’ 
TraJ (299-509)*** 
 
5’- TTACGATCTCCGGAGGAATTTTTCCCTGCGTGACTGGC 
TT-3’  
Effector genes 
Ats-1 5’-GTGCTCCATATG1CTAATAAGAAGAATTCTG-3’ 
5’-GTAATTGGTACC4CTCGAG2TTACCTCGTACCTTTACC-3’ 
Ats-1 CTD Forward 5’-GTACTTCATATG1GAACGCATTTTCTCATTG-3’ 
Aph_0111 5’-GGACTGCATATG1TCAATCGATTGT-3’ 
5’-TTGCGCCTCGAG2CTATCCAGATATAG-3’ 
WD0636 5’-GCCGAGCATATG1AGTAAAAAAGAAAAAGAG-3’ 
5’-CACGGTACC4TCATAATTTCTCAAATAACTTTTC 
WD0811 5’-GTCCATATG1ATGATATCCAATAATTCT-3’ 
5’-GATGGTACC4TCAATTCATTTGTAA-3’ 
WD0830 5’-TCGTAGCATATG1AAACAAGGAGATAAG-3’ 
5’-GTAGGTACC4TTACACTGTTCCTGGAGT 
VirE3 5’-GATGCATATG1GTGAGCACTACGAAG 
5’-GATCGGTACC4TTAGAAACCTCTGGAGG 
VirF 5’-GCACCATATG1AGAAATTCGAGTTTGCG 
5’-GATATTGGTACC4TCATAGACCGCGCGTTG 
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Other primers 
Cre 5’-GATAGAGCTC5AGGAGGTATTCACCATGTCCAATTTACT 
GACCGTACACCAAAATTTGC-3’ 
5’-CATGGTACC4TATATATCATATG1ATCGCCATCTTCCAGC 
AGGC-3’ 
TraJ deletion 5’-CTGGGAACCAAAAAAGGAGCGCTGACCATGG3GTTGGG 
TAACGCCAGGGTTTTCC-3’ 
5’-TGGCGGGTAATCGTGGTTATATCAACCATGG3CACACAG 
GAAACAGCTATGACCATGATTAC-3’ 
 
Underlined restriction sites are as follows:  1NdeI (CATATG), 2XhoI (CTCGAG), 3NcoI 
(CCATGG), 4KpnI (GGTACC), 5SacI (GAGCTC), 6BspHI (TCATGA) 
*TraJ::VirD4ApΔC was constructed via inverse PCR by insertion of a stop codon. 
**Chimeras TraJ::VirD4Wp and TraJ::VirD4WpΔ574 were constructed by overlapping PCR 
using the TraJ forward primer. Internal and reverse primers are specified. 
***The TraJ+VirD4AtAAD chimera was constructed using the same forward primer as TraJ 
TMD and the same reverse primer as TraJ. 
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Construction of virD4 deletion strains and chimeric virD4 plasmids 
The virD4 null strain Mx355 contains an IncP plasmid, pPH1JI [27, 49], which 
encodes resistance to gentamicin, chloramphenicol, spectinomycin, and streptomycin. 
Mx355 was cured of pPH1JI as follows. ColE1 plasmids containing VirD4 homologs behind 
a PVirB promoter (Table 2.1) were ligated to another IncP plasmid, pXZ151 [39].  The 
resulting co-integrates were introduced to Mx355 cells by electroporation [50] and 
transformants were plated on high concentrations of kanamycin (300 µl/ml).  Colonies were 
consecutively streaked for isolation on kanamycin plates for two overnight growth cycles, 
after which colonies were patched on gentamicin (100 µg/ml) to test for sensitivity as an 
indicator of pPH1JI curing. 
A traJ deletion in pKM101-Spcr (Table 2.1) was obtained by recombineering [51-53]. 
pKM101-Spcr was conjugatively transferred into E. coli strain HME45 [51, 53], which 
contains a defective λ prophage that can be temperature induced to activate Red 
recombination. In this system, the λ Red subunits Exo and Beta use single strand annealing 
to generate recombinants.  The Exo subunit is a 5’-3’ exonuclease that is thought to bind the 
end of a dsDNA fragment during replication, while the Beta subunit is a ssDNA binding 
protein that promotes annealing between complementary ssDNA.  Briefly, upon degradation 
of dsDNA by Exo, Beta binds 3’ ssDNA overhangs.  Introduction of the complementary 
sequence (e.g. PCR product) allows Beta to anneal the two complementary stands to 
generate recombinants.   
A linear DNA fragment containing a cassette conferring Kanr from the plasmid 
pUC4K, flanked by NcoI restriction sites, was PCR amplified using primers 5’-
CTGGGAACCAAAAAAGGAGCGCTGACCATGGGTTGGGTAACGCCAGGGTTTTCC-3’ 
and 5’-
TGGCGGGTAATCGTGGTTATATCAACCATGGCACACAGGAAACAGCTATGACCATGATT
AC-3’, bearing 25 bp of sequence homology to the regions upstream and downstream from 
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traJ, respectively (Table 2.2).  The purified PCR product was electroporated into HME45 
cells containing pKM101-Spcr after temperature induction and Kanr recombinants were 
selected.  pKM101-Spcr is a multicopy plasmid, and recombination does not occur on all 
copies within a single cell.  Therefore, it was necessary to isolate a strain carrying only the 
traJ-deleted plasmid.  For this, Kanr colonies were sequentially grown in LB broth containing 
kanamycin (200 µg/ml) for 4 days prior to plating for isolated colonies on LB plates 
containing kanamycin (200 µg/ml).  The kanr cassette was deleted by NcoI digestion and re-
ligation of the pKM101-Spcr plasmid. The traJ deletion was confirmed by absence of a PCR 
product corresponding to traJ using primers 5’-CAGTAGCCATGGACGATAGAGAAAGA-3’ 
and 5’-ACAATTGGTACCTCAGATCTCCCTCAG-3’ (Table 2.2).  
Plasmids pTB51 and pTB52 express the traJ::virD4Wp and traJ::virD4WpΔ574 
chimeric T4CP’s, respectively, from the PBAD promoter.  These plasmids were created by 
overlapping PCR [47, 48] with the gene fragments corresponding to the TraJ TMD and the 
respective SD fragments of VirD4Wp.  PCR products were digested with NcoI and KpnI, and 
the resulting fragments were ligated into similarly digested pBAD24 [42] or pBAD24-Kanr.  
Plasmid pTB38 encodes traJ::virD4Ap within the vector plasmid pMK-RQ; the traJ::virD4Ap 
gene fragment was synthesized and codon optimized for use in E. coli  by Invitrogen. 
Plasmid pTB39 expresses traJ::virD4Ap from the PBAD promoter.  The traJ::virD4Ap gene 
fragment was obtained as an NcoI/KpnI fragment from pTB38, and inserted into similarly 
digested pBAD24. Plasmid pTB50 expresses traJ::virD4ApΔ574 which encodes the 
TraJ::VirD4 chimeric T4CP deleted of C-terminal residues 574-740. This plasmid was 
generated by inserting a stop codon at codon 574 of pTB39 by inverse PCR with primers 5’-
TTCCGGGTCATAAGGTTCTTGG-3’ and 5’-TAAATTCGTGGTGGTGTTGAAGG-3’ (Table 
2.2).   
Plasmid pNW1 expresses coding sequence for the TraJ TMD from the Plac promoter.  
It was constructed by Dr. N. Whitaker by amplification of coding sequence for the TraJ TMD 
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from a pKM101 template using primers 5’-
CATACCATGGACGATAGAGAAAGAGGCTTAGCATTTTTATTTG-3’ and 5’-
GTATCTCGAGTATATATCATATGATAAATGATAAAAGCGATCAGACCGCCAAC-3’ (Table 
2.2). The PCR product was digested with NcoI and XhoI, and the resulting fragment was 
ligated into similarly digested pBSIIKS+ [32].  Plasmid pNW2 expresses the traJ::virD4At 
chimeric T4CP from the Plac promoter.  It was constructed by inserting coding sequence for 
the SD of VirD4At, obtained as an NdeI/XhoI fragment from pKA38 [45], into similarly 
digested pNW1. Plasmid pNW4 expresses traJ::virD4AtΔ553 from the Plac promoter.  The 
sequence encoding the VirD4At SD without residues 553-656 was PCR amplified using 
pKA38 as a template and primers 5’- 
CATATATATACATATGAATCAGAAGCATCACGGGACGG-3’ and 5’- 
GTTCTCGAGTCAAGGGTGCGGGCTCAGGCAG-3’ (Table 2.2).  The PCR product was 
digested with NdeI and XhoI and the resulting fragment was ligated to similarly digested 
pNW1.  Plasmid pNW6 expresses traJ::virD4AtΔAAD from the Plac promoter. The sequence 
encoding the VirD4At SDΔAAD, obtained as an NdeI/XhoI fragment from plasmid pCM39, 
was inserted into similarly digested pNW1. 
Plasmid pNW10 expresses traJ::virD4At with AADtraJ from the Plac promoter.  The 
sequences encoding amino acids 1-190 of the TraJ::VirD4At chimera expressed by pNW2, 
the AAD domain of TraJ (amino acids 186-298), and amino acids 347-656 of VirD4At were 
PCR amplified using primers 5’-TCATGAATGGACGATAGAGAAAGAGG-3’ and 5’-
GAAAAACACCCAGCCAGAATCTAGGGGGGAAAACTTGAAAAC-3’, 5’-
TCCCCCCTAGATTCTGGCTGGGTGTTTTTCAATGAAA-3’ and 5’-
AATGCAGGTCTTCTTACCTTCCGGCATTTTCAAATGTG-3’, and 5’-
AAAATGCCGGAAGGTAAGAAGACCTGCATTTATCTTTGTGTCAGTC-3’ and 5’-
CTCGAGTCATTTCGCAGGCTGGTGCCGGTGC-3’ (Table 2.2).  Overlapping PCR was 
used to amplify the three PCR products together as a single product with outside primers 
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from the first and third reactions.  The final PCR product was digested with BspHI and XhoI 
and the resulting fragment was ligated into similarly digested pBSIIKS+. Plasmid pNW11, 
expresses traJ with AADvirD4At from the PBAD promoter.  The sequences encoding TraJ amino 
acids 1-185, VirD4At AAD (amino acids 132-346), and the amino acids 299-509 of TraJ were 
PCR amplified using primers 5’-CATACCATGGACGATAGAGAAAGAGGCTTAGCATTTTT 
ATTTG-3’ and 5’- ATGAGTCTTCCGCTCTTCAGTGCGTTTATCATAGGCG-3’, 5’-
GATAAACGCACTGAAGAGCGGAAGACTCATTGTTACAATCC-3’ and 5’- 
CACGCAGGGAAAAATTCCTCCGGAGATCGTAAACGGAA-3’, and 5’- 
TTACGATCTCCGGAGGAATTTTTCCCTGCGTGACTGGCTT-3’ and 5’-
ACAATTGGTACCTCAGATCTCCCTCAG-3’ (Table 2.2).  Overlapping PCR was used to 
amplify the three PCR products together as a single product with outside primers from the 
first and third reactions.  The final PCR product was digested with NcoI and KpnI and the 
resulting fragment was ligated into similarly digested pBAD24.  All chimeric constructs were 
verified by sequencing. 
 
Construction of Cre fusion plasmids 
 The plasmid pBAD33-Cre was prepared by PCR amplification of the cre insert, using 
pZD96 as a template and the primers 5’-
GATAGAGCTCAGGAGGTATTCACCATGTCCAATTTACTGACCGTACACCAAAATTTGC-
3’ and 5’-CATGGTACCTATATATCATATGATCGCCATCTTCCAGCAGGC-3’  (Table 2.2).  
PCR products incorporated a SacI site followed by the Shine-Dalgarno sequence (AGG 
AGG) at the 5’ end and NdeI and KpnI sites at the 3’ end. The two restriction sites at the 3’ 
end allows for the creation of Cre-effector fusion proteins.  The PCR product was digested 
with SacI/KpnI and the resulting fragment was ligated to similarly digested pBAD33 [42].  
Known or putative effector genes were PCR amplified or isolated as described in Table 2.1.  
The DNA fragments were digested with NdeI/KpnI or NdeI/XhoI, and the resulting fragments 
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were ligated to similarly digested pBAD33-Cre to create translational fusions.  All constructs 
were verified by restriction digestion analysis and sequencing. 
 
Protein analysis by western blot 
 To assay for the accumulation of Cre-effector fusion proteins, arabinose induced 
cells were harvested at mid-log phase and normalized to equivalent optical densities 
(OD600), re-suspended in Laemmli’s buffer (50 mM Tris-HCl, 4% SDS, 20% glycerol, 20 mM 
dithiothreitol, 1% β-mercapatoethanol, 0.1% bromophenol blue, pH 6.8), and boiled for 10 
minutes.  The boiled cell lysates were resolved by sodium dodecyl sulfate polyacrylamide 
gel electrophoresis (SDS-PAGE) as previously described [54], with modifications.  Proteins 
were transferred to polyvinylidene fluoride (PVDF) membranes and incubated with anti-Cre 
antibodies (Novus Biologicals) overnight.  Western blots were developed with goat anti-
mouse antibodies conjugated to horseradish peroxidase (HRP; New England Biolabs), and 
visualized by chemiluminescence (Thermo Scientific). 
 
Conjugation assays 
A. tumefaciens and E. coli donor strains were assayed for conjugative DNA transfer 
through the VirB/VirD4 and pKM101-encoded T4SSs as follows [33, 36, 55].  The 
promiscuous, mobilizable IncQ plasmid pML122ΔKm [40, 55] served as a DNA substrate.  
For A. tumefaciens conjugative matings, pML122ΔKm was introduced by electroporation 
[56] together with the ColE1/pXZ151 co-integrates described above into wild-type strain 
A348 or the Mx355 (virD4-) mutant.  These strains functioned as donors with A348-Spcr as a 
recipient in mating experiments [36, 40].  Conjugative matings were carried out as 
previously described [55].  Briefly, A. tumefaciens strains were induced 16-18 hours at room 
temperature, as described above.  Cells were mixed in a 1:5 ratio of donors to recipients 
and spotted onto sterile nitrocellulose filters placed on ABIM agar plates. Suspensions of 
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donors only and recipient only were also spotted onto filters to serve as controls.  Plates 
were incubated for 4-5 days at 18 °C. Cells were re-suspended in 1x PBS and serial 
dilutions were prepared.  Dilutions were spread on antibiotic containing MG/L plates 
selecting for donors, recipient, and transconjugants.  Frequency of transfer was calculated 
as the number of transconjugants per donor cell.  Mating experiments were carried out at 
least three times in duplicate, and results are reported as mean frequency of transfer with 
standard deviations indicated. 
E. coli conjugation assays were carried out as previously described [57], with strains 
DH5α and WM1650 serving as the donor and recipients, respectively.  Briefly, strains were 
grown overnight with antibiotic selection in LB broth at 37 °C.  Cells were then diluted 1:10 in 
fresh LB with the addition of 0.2% arabinose or 200 µM IPTG as appropriate for plasmid 
induction, and grown at 37 °C for 1 hour.  Donors and recipients were mixed in a 1:1 ratio 
and centrifuged for 1 min.  Cells were re-suspended in 20 µl of the supernatant and spotted 
onto sterile filters placed on LB induction plates.  Suspensions of donors alone and the 
recipient alone were prepared simultaneously as controls.  After overnight incubation at 37 
°C, cells were re-suspended in 1x PBS and serial dilutions were plated on LB plates 
selecting for donors, recipient, and transconjugants.  Frequency of transfer was calculated 
as the number of transconjugants per donor.  All mating experiments were performed at 
least three times in duplicate or triplicate, and results are reported as the mean frequency of 
transfer with standard deviations indicated. 
 
Virulence assays 
 A. tumefaciens strains were assayed for T-DNA and effector protein transfer using a 
tumor formation assay on Kalanchoe daigremontiana leaves [24, 39].  Wild-type A348 and 
avirulent strain Mx355 (virD4-) served as positive and negative controls, respectively.  
Briefly, bacterial strains were freshly streaked on MG/L agar plates with the appropriate 
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antibiotics and grown at room temperature for 2 days.  Plant leaves were wounded by 
scratching with a sterile toothpick and immediately inoculated with cells from the 2-day 
plates.  All strains were inoculated onto at least 5 different leaves and virulence was 
assessed after 6-8 weeks. 
 
CRAfT (Cre-recombinase Reporter Assay for Translocation) 
 The Cre fusion reporter [5] was used to assay for the translocation of known or 
putative effector proteins from E. coli MS411 donor cells into the recipient E. coli strain 
CHS26Cm::LTL, which contains a loxP-Tetr-loxP cassette interrupting a cat gene on the 
bacterial chromosome [33].  Plasmid pBBR1MCS2-Genr was introduced into the recipient 
strain for additional antibiotic selection of recombinants.  Cre-mediated excision in the 
recipient strain results in colonies exhibiting a Camr, Genr, Tets phenotype.  This recipient 
strain produced higher than desired levels of background growth (i.e. growth on Cre-only 
controls).  Several experiments were repeated with another recipient generated by plating 
100 ml of CHS26Cm::LTL liquid cell culture on LB plates containing 50 µg/ml of rifampicin.  
After growing at 37 °C overnight, Rifr colonies were selected and made competent.  The 
non-mobilizable plasmid pUC4K, encoding resistance to carbenicillin and kanamycin, was 
introduced to the Rifr recipient to produce CHS26Cm::LTL,rifr(pUC4K).  The latter recipient 
genrally confirmed the results observed with the former recipient, while diminishing the 
background growth.  Results are reported using the original CHS26CM::LTL(pBBR1MCS2-
Genr) recipient unless otherwise noted. 
CRAfT was performed similarly to the conjugation assay described above.  Briefly, 
strains were grown overnight in LB broth with antibiotic selection at 30 °C.  Cells were 
diluted 1:10 into fresh LB containing 0.2% arabinose or 200 µM IPTG as appropriate for 
plasmid induction, and grown at 30 °C for 1 hour.  Cell suspensions were normalized by 
OD600. Donor and recipient cells were mixed in a 1:1 ratio and centrifuged for 1 min.  Cell 
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pellets were re-suspended in 20 µl of the supernatant and spotted onto sterile nitrocellulose 
filters on LB induction plates.  Concurrently, donors alone and recipient alone were prepared 
as controls.  Plates were incubated overnight at 30 °C.  Cells were re-suspended in 1x PBS 
and serially diluted.  Donors, recipient, and recombinants were selected for on LB agar 
plates containing the appropriate antibiotics.  Frequency of recombination was calculated as 
the number of recombinants per donor.  All CRAfT experiments were performed at least 
three times in duplicate, and results are reported as the mean frequency of recombination 
with standard deviations. 
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Chapter 3.  Chimeric T4SS in Agrobacterium and Functional Characterization of the 
VirD4At C-terminal Extension 
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Introduction 
The A. tumefaciens VirB/VirD4 T4SS is comprised of a channel that directs 
oncogenic T-DNA and effector proteins across the cell envelope and into plant cells during 
infection [6, 58].  Previous studies from our lab have shown that the VirD4 T4CP functions 
as a receptor for the DNA and protein substrates of the VirB/VirD4 T4SS [8, 59, 60].  A. 
tumefaciens is a member of the Alphaproteobacteria and is closely related phylogenetically 
to Rickettsial species (Figure 3.1A).  Members of the Rickettsiales are intracellular 
pathogens and they also carry virB/virD4-like genes in their genomes (Figure 3.1B).  
Therefore, the Rickettsia spp. are postulated to assemble T4SSs resembling the A. 
tumefaciens VirB/VirD4 T4SS for the purpose of delivering effector proteins into the 
mammalian host during infection.  However, studies of Rickettsial pathogens are currently 
hampered by the inability to grow these pathogens in laboratory media and also because 
they are genetically intractable.   
Here, I sought to test whether T4CP’s from three Rickettsial species, A. 
phagocytophilum, R. rickettsii Sheila Smith strain, and W. pipientis, could functionally 
substitute for the A. tumefaciens VirD4 subunit to mediate translocation of DNA or protein 
substrates.  The overarching goal was to use A. tumefaciens as a surrogate host and 
chimeric T4SSs composed of A. tumefaciens VirB subunits and Rickettsial VirD4 subunits, 
first, to gain evidence that the Rickettsial VirD4 subunits are functional, and second, to 
identify novel protein substrates that are translocated through Rickettsial VirB/VirD4 T4SSs.   
This line of study gains support from previous work showing that substitutions of 
VirD4 subunits with closely related homologs enable assembly of functional T4SS’s [9, 61].  
Here, to test whether Rickettsial VirD4 homologs could form a chimeric T4SS in A. 
tumefaciens, I assayed for the capacity of virD4 genes from A. phagocytophilum (virD4Ap), 
R. rickettsii (virD4Rr), and W. pipientis (virD4Wp) to complement the virD4At null mutation.  
The initial complementation tests assayed for i) translocation of the T-DNA and protein 
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effectors to plant cells using a virulence assay and ii) translocation of the promiscuous, 
mobilizable IncQ plasmid to A. tumefaciens recipients.  I also assayed for the capacity of 
Rickettsial virD4 genes to exert negative dominance when expressed in an otherwise wild-
type A. tumefaciens background.    
Finally, as discussed earlier, VirD4At and other T4CPs, including those from A. 
phagocytophilum and W. pipientis, carry C-terminal extensions compared with T4CPs such 
as pKM101-encoded TraJ or the structural prototype for the T4CP family, E. coli TrwBR388.  
These CTEs are typically variable with an overall negative charge, and I sought to test 
whether the A. tumefaciens VirD4 T4CP requires its CTE for function. I was unable to 
demonstrate that the chimeric T4SSs functioned to translocate substrates, however, I 
gained genetic evidence for poisoning interactions between the Rickettsial T4CPs and the 
A. tumefaciens VirB system.  I also demonstrated that VirD4At’s CTE is required for 
translocation of T-DNA and the VirE2 effector protein to plant cells, but dispensable for 
translocation of the promiscuous IncQ plasmid to Agrobacterial recipients.  
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Figure 3.1  Diversity of T4SSs in Alphaproteobacteria 
A. Phylogenetic tree indicating the close relationship between A. tumefaciens and 
Rickettsial species.  This image is modified from Beninati, et al. 2004 to indicate 
species presented in this thesis [62].  Permission for use was granted by the 
American Society for Microbiology.   
B. Comparison of T4SSs between species of the Rickettsiales and other bacterial 
species.  This image was modified from Gillespie, et al. 2010 to highlight the species 
presented in this thesis [17].  Permission for use was granted by the American 
Society of Microbiology.  At, A. tumefaciens; Ec, E. coli; Rt, Rickettsia sp.; Wp, 
Wolbachia pipientis; Ap, A. phagocytophilum. 
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Results 
 
Rickettsial VirD4 homologs do not complement a virD4 mutant for substrate transfer 
To test the ability of Rickettsial VirD4 homologs to functionally substitute for A. 
tumefaciens VirD4, I first cloned the virD4 genes from plasmids obtained from the labs of 
Katrin Gentil and Yasuko Rikihisa, as described above.  For expression in A. tumefaciens, I 
cloned each of the genes downstream of the acetosyringone-inducible virB promoter (PvirB) 
on a ColE1 plasmid.  I then ligated the ColE1-based virD4 expression plasmids to an IncP 
plasmid, which replicates in A. tumefaciens.  I introduced the virD4 expression plasmids into 
the virD4 mutant strain Mx355 or the wild-type strain A348 to assay for functionality or 
negative dominance, respectively.  I confirmed the presence of the plasmids and virD4 
genes of interest in the different A. tumefaciens strains by PCR amplification with the 
primers originally used to clone the genes. It is important to note that much of this work 
using the plasmid containing virD4Rr yielded negative results and it was later discovered that 
the construct provided to our lab contained a deletion of ~100 bp.  This construct, and any 
data generated, has been left out of this thesis.  Several attempts to generate the correct 
construct failed, although I was able to clone virD4Rr behind a PBAD promoter for use in E. 
coli as discussed in chapter 4. 
I first assayed for the capacity of Mx355 carrying the virD4-expression plasmids to 
translocate the A. tumefaciens T-DNA and effector proteins to plants, as monitored by 
virulence on Kalanchoe leaves. As shown in Figure 3.2, A. tumefaciens strains A348 (WT) 
and Mx355 (ΔvirD4) expressing virD4At incited tumors within 6-8 weeks on plant leaves, 
although the latter strain incited tumors that were reproducibly smaller than WT A348.  By 
contrast, Mx355 expressing the Rickettsial virD4Ap, or virD4Wp genes failed to incite virulence 
on plants.   
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Both A348 and Mx355 expressing virD4At mobilize the transfer of the nonself-
transmissible IncQ plasmid pML122 into agrobacterial recipients.  I introduced pML122 into 
the above strains to assay for the capacity of the Rickettsial virD4 genes to mobilize IncQ 
transfer. As shown in Figure 3.2B, A348 and Mx355 expressing virD4At mobilized IncQ 
plasmid transfer at frequencies of ~10-4 transconjugants per donor (Tc’s/D). By contrast, 
Mx355 expressing the Rickettsial virD4 genes failed to mobilize transfer of the IncQ plasmid.  
Taken together, these findings suggest that the Rickettsial virD4 genes do not functionally 
substitute for virD4At for transfer of A. tumefaciens DNA or protein substrates.  
Protein levels of the VirD4 homologs could not be assessed at this time, as 
antibodies were not available and previous attempts to attach an N- or C-terminal tag to 
VirD4At have rendered it non-functional.  Polyclonal antibodies against VirD4At were tested 
for cross-reactivity with the VirD4 homologs, however detection of the homologs by western 
blot was not successful.  Therefore, it is unknown if lack of complementation by the 
Rickettsial virD4 genes is due to problems in gene expression, instabilities of the 
synthesized T4CPs, or the inabilities of the T4CPs to recognize the A. tumefaciens 
substrates.   
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Figure 3.2  Tests for complementation of the A. tumefaciens ΔvirD4 mutation by virD4 
genes from Rickettsial species.   
A. T-DNA and effector protein transfer as monitored by virulence on wounded 
Kalanchoe leaves.  Representative leaf showing tumor induction of wild-type (WT) 
strain A348, ΔvirD4 mutant Mx355, and Mx355 expressing virD4At, virD4Ap, or 
virD4Wp.   
B. DNA substrate transfer frequency and virulence data.  Conjugative transfer 
frequency of the IncQ plasmid, pML122, is presented as transconjugants per donor 
cell (black bars) with standard deviations indicated.  Virulence on plant leaves (white 
bars), as measured on a scale of three pluses (as incited by the WT strain), two and 
one pluses for attenuated virulence, minus sign, avirulent.  * IncQ plasmid transfer is 
statistically significant when compared to WT (P<0.0001) 
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Evidence for expression of virD4 homologs in A. tumefaciens A348 
To examine the possibility that the Rickettsial VirD4 T4CPs interact nonproductively 
with the A. tumefaciens VirB channel or VirB/VirD4 substrates, I tested whether A348 strains 
carrying the virD4 expression plasmids displayed altered substrate transfer as monitored by 
plant virulence assays and IncQ plasmid mobilization.   As shown in Figure 3.3, A348 
carrying a plasmid expressing virD4At displayed a slight reduction in virulence as shown by 
slightly smaller tumors than WT A348.  A348 carrying the virD4Wp expression plasmid also 
showed a slight attenuation in virulence.  However, A348 carrying the virD4Ap expression 
plasmid was highly attenuated for virulence, consistent with the idea that VirD4Ap somehow 
poisons substrate engagement with or transfer through the VirB/VirD4 T4SS.   
A348 strains carrying the virD4 expression plasmids were also assayed for 
mobilization of the IncQ plasmid pML122.  As shown in Figure 3.3, trans-expression of all of 
the virD4 homologs including virD4At resulted in a slight reduction of ~1 order of magnitude 
in IncQ plasmid transfer compared with WT A348, although this was not a statistically 
significant decrease from wild-type transfer.  All of the trans-expressed virD4 genes were 
from an IncP replicon, whose copy number is estimated at ~5 times that of the Ti plasmid, 
which carries the virB and virD4 genes as well as the oncogenic T-DNA and effector genes.  
The observed dominant negative effects accompanying trans-expression of the virD4 genes 
on virulence and IncQ plasmid transfer could arise from overproduction of the VirD4 T4CPs.  
The overproduced T4CPs might interact nonproductively with the VirB machinery, creating 
nonfunctional secretion channels, or they might sequester DNA or protein substrates and 
prevent their engagement with the native VirB/VirD4 machine. 
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Figure 3.3  Tests for dominant negative effects of virD4 genes from Rickettsial 
species expressed in wild-type A. tumefaciens strain A348  
DNA substrate transfer frequency and virulence data.  Conjugative transfer frequency of the 
IncQ plasmid, pML122, is presented as transconjugants per donor cell (black bars) with 
standard deviations indicated.  Virulence on plant leaves (white bars), as measured on a 
scale of three pluses (as incited by the WT strain), two and one pluses for attenuated 
virulence, minus sign, avirulent.  WT, A348; WT strain expressing the virD4 genes indicated.  
Expression of virD4 genes in trans did not cause a statistically significant decrease in IncQ 
transfer compared to wild-type (P>0.05). 
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The C-terminal extension (CTE) of VirD4At is important for virulence but not for IncQ 
transfer 
The VirD4 family members share generally high sequence conservation among their 
nucleotide-binding domains, but are considerably more variable among their TMD’s, AAD’s, 
and CTE’s. The TMD’s are implicated in mediating interactions with transfer channels [9], 
and their sequence variation could be attributable to an evolved specificity in interaction with 
the cognate T4SS channel.  The variations in the AAD’s and/or CTE’s however, might be 
important for evolved specificity in engagement of effector proteins with cognate T4SS 
channels. As mentioned above, AAD’s within the Rickettsial species are quite conserved, 
suggesting that if this domain contributes to substrate docking, substrates are likely very 
similar between these species.   
Sequence analysis of several T4SSs revealed that T4SSs dedicated to translocation 
of protein effectors generally possess CTE’s of variable length and amino acid composition; 
whereas systems dedicated to conjugative DNA transfer typically lack CTE’s.  Among the 
Rickettsial homologs in this study, the VirD4 subunits possess variable C-terminal domains 
from 21-167 residues that are highly enriched in acidic residues (Figure 1.4), e.g., VirD4Ap 
CTE has 47% Glu/Asp residues. In A. tumefaciens, the VirB/VirD4 T4SS functions both in 
DNA and protein transfer.  In this system, the CTE is 104 residues with 16% being acidic. In 
well-characterized E. coli conjugative plasmids, R388 and pKM101, the VirD4 orthologs lack 
CTE’s altogether.   
Given these findings, I hypothesized that the C-termini of the VirD4 subunits 
contribute to substrate specificity either by a) acting as a docking point for effectors prior to 
translocation or b) blocking DNA translocation thereby only allowing protein substrates to be 
translocated.  To test this hypothesis, I created a virD4 allele encoding VirD4AtΔ553, which is 
deleted of its CTE, and assayed for functional complementation of a virD4 null mutation.  As 
shown in Figure 3.4, Mx355 producing full length VirD4At incites formation of plant tumors 
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and transfers the IncQ plasmid at WT frequencies, whereas Mx355 producing VirD4AtΔ553 
was avirulent on plants but displayed near wild-type levels of IncQ plasmid transfer.  These 
findings suggest that the CTE is necessary for VirD4 to interact productively with A. 
tumefaciens virulence factors, but is dispensable for interaction and translocation of the 
promiscuous IncQ plasmid.  Further studies of VirD4’s CTE are described in Chapter 5. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  	   45	  
 
 
 
 
 
 
 
Figure 3.4.  Contribution of the C-terminal extension of A. tumefaciens VirD4 to 
substrate transfer  
DNA substrate transfer frequency and virulence data.  Conjugative transfer frequency of the 
IncQ plasmid, pML122, is presented as transconjugants per donor cell (black bars) with 
standard deviations indicated.  Virulence on plant leaves (white bars), as measured on a 
scale of three pluses (as incited by the WT strain), two and one pluses for attenuated 
virulence, minus sign, avirulent.  WT, A348; ΔvirD4 mutant, Mx355; virD4 expressing wild-
type virD4 or virD4AtΔ553. * IncQ plasmid transfer is statistically significant when compared 
to WT (P<0.0001) 
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  Discussion 
 
Transfer of effector molecules using VirD4 homologs in the Agrobacterium type IV 
secretion system 
 The use of chimeric and surrogate T4SSs has been established in a variety of 
contexts [9, 20, 22, 23].  This study was aimed at determining whether VirD4 homologs 
assemble with the A. tumefaciens VirB subunits to form functional chimeric T4SSs.  I 
expressed virD4 genes from two Rickettsial homologs, A. phagocytophilum and W. pipientis, 
in a virD4-mutant background and determined that they were unable to form a functional 
chimeric T4SS, at least with respect to the translocation of A. tumefaciens effectors or the 
promiscuous IncQ plasmid pML122.  This is not entirely surprising, as I was assaying for 
translocation of non-cognate substrates, and at this time there is no evidence that Rickettsial 
species are capable of interbacterial conjugation or mobilization of IncQ plasmids. 
 I also expressed the Rickettsial virD4 genes in the A. tumefaciens strain A348 to 
genetically test for dominant effects of these genes over virD4At. I determined that trans-
expression of the wild-type virD4At gene as well as the virD4Ap and virD4Wp genes conferred 
negative dominance both with respect to plant tumorigenesis and IncQ plasmid transfer, 
although the latter was found not to be statistically significant.  To account for negative 
consequence of virD4At trans-expression, I propose that synthesis of VirD4 from the higher 
copy number IncP replicon compared with the Ti plasmid results in elevated copies of the 
T4CP which interferes with assembly of functional VirB/VirD4 T4SSs or binds available 
substrates preventing their interaction with functional VirB/VirD4 T4SSs.  The finding that 
the Rickettsial virD4 genes, in particular virD4Ap, also exerted negative dominance, suggests 
first that the Rickettsial T4CPs are synthesized and second that they similarly ‘poison’ 
substrate transfer through the VirB/VirD4 T4SS.   
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 At this time, it is not known how the trans-expressed virD4 genes negatively affect 
substrate transfer through the VirB/VirD4 T4SS.  It is possible that expression of the 
Rickettsial virD4 genes from a single copy plasmid or integration into the Ti plasmid would 
enable functional complementation of the virD4At- mutation with respect to translocation of 
the A. tumefaciens effectors or IncQ plasmids.  It is also possible that the Rickettsial VirD4 
T4CPs in fact do interact productively with the A. tumefaciens VirB channel subunits, but 
only for translocation of Rickettsial substrates.  Although this remains to be tested, such 
studies using A. tumefaciens as a surrogate host are complicated because of the difficulty of 
genetic manipulation of this bacterium compared to other commonly used model bacterial 
species such as E. coli.  In Chapter 5, I present results of my studies using E. coli as a 
surrogate host in which I demonstrate functionality of chimeric VirD4 T4CPs composed of a 
TMD from an E. coli plasmid-encoded T4CP and SDs from A. tumefaciens or Rickettsial 
T4CPs.  These studies demonstrate a proof-of-principle for the use of chimeric T4CPs, and 
warrant future investigations testing whether native or chimeric Rickettsial T4CPs can 
mediate translocation of Rickettsial substrates through the A. tumefaciens VirB channel.  
 
The CTE of VirD4At is required for translocation of some, but not all, substrates 
There is already experimental support for the idea that T4CP CTEs contribute to 
substrate engagement.  In the E. coli F-plasmid transfer system, the TraD T4CP carries a 
CTE and this CTE has been shown to bind the TraM accessory factor [12].  TraM is an 
essential component, along with the TraI relaxase, of the relaxosome that assembles at the 
F-plasmid origin-of-transfer (oriT) sequence.  Consequently, the TraD CTE-TraM interaction 
serves to physically couple the relaxosome with the transfer channel prior to plasmid 
transfer.  In addition, although the F-plasmid transfer system mobilizes promiscuous IncQ 
plasmids, it does so only at very low frequencies of <10-6 Tc’s/D, whereas this T4SS 
transfers the F-plasmid at high frequencies exceeding 101 Tc/D.  Deletion of TraD’s CTE, 
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however, reverses this pattern, so that the T4SS instead translocates the F-plasmid at low 
frequencies and the IncQ plasmids at comparatively high frequencies.  Therefore, TraD’s 
CTE confers substrate specific docking of the F-plasmid substrate and blocks IncQ plasmid 
transfer.   
In this study, phenotypic analysis of the VirD4AtΔ553 derivative deleted of the CTE 
confirmed the importance of the CTE for translocation of A. tumefaciens substrates required 
for plant virulence. Yet, this construct supported IncQ plasmid transfer to recipient 
agrobacteria at near wild-type levels, indicating that the CTE is not required for recruitment 
or translocation of the IncQ plasmid.  These findings support a general model in which the 
promiscuous IncQ plasmids have evolved to interact with domains or motifs that are 
conserved among members of the T4CP superfamily, e.g., possibly the NBD or AAD, 
whereas the CTE contributes to engagement of substrates that are dedicated for 
translocation through a given T4SS. In Chapter 6, I further analyze the effect of deleting 
VirD4’s CTE on DNA and protein transfer using an E. coli chimeric T4SS, and results further 
support the idea that the CTE functions as a substrate specificity domain.   
After completing these studies with A. tumefaciens as a surrogate host, I determined 
that the best strategy for increased translocation efficiency would be to assay for 
translocation of native substrates for each of the different VirD4 homologs. Additionally, I 
wanted to develop a surrogate host system that was more amenable to genetic 
manipulation, and a system in which substrate transfer could be assessed more rapidly and 
quantitatively than with the A. tumefaciens virulence assay.  It is also noteworthy that in A. 
tumefaciens, mobilization of IncQ plasmids through the VirB/VirD4 system occurs at low 
frequencies  (e.g., the frequency of IncQ plasmid transfer is 10-4 Tc’s/D after a five-day 
mating).  By contrast, E. coli conjugation systems such as the pKM101-encoded system 
which bears strong overall similarity to the A. tumefaciens VirB/VirD4 system, transfers IncQ 
plasmids and other plasmid substrates at considerably higher frequencies in 1 - 2 hour 
	  	   49	  
matings.   For these reasons, I focused the remainder of my studies on development of E. 
coli as a surrogate host to characterize the functionality of chimeric T4SSs and monitor 
translocation of heterologous T4SS effector proteins.  
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Chapter 4.  The Type IV Secretion System of Escherichia coli pKM101 and Related 
Chimeric Systems Mediate Translocation of Heterologous Protein Substrates 
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Introduction 
 The broad-host range conjugative IncN plasmid pKM101, a derivative of R46, has 
been studied extensively as an efficient and easily manipulated T4SS [43]. This plasmid 
conjugatively transfers from E. coli donors to recipients in 1 h filter matings at efficiencies 
≥10-1 transconjugants per donor (Tc’s/D) [43].   By contrast, the A. tumefaciens VirB/VirD4 
system delivers IncQ plasmid substrates to agrobacterial recipients at frequencies of 10-4-
10-5 Tc’s/D in 4-5 day filter matings (Figure 3.2).  The highly efficient pKM101 transfer 
system, coupled with the ease of genetic manipulation of E. coli, makes this an ideal system 
for detailed mechanistic studies of type IV secretion in Gram-negative bacteria. 
 Transposon mutational analyses in the 1980’s identified the regions of pKM101 
required for conjugative DNA transfer [43, 63]. More recently, the plasmid was sequenced, 
enabling precise definition of the transfer (tra) genes and their putative functions [64].  One 
tra gene cluster, closely resembling the A. tumefaciens virB genes both in composition and 
gene order, codes for the transfer channel.  The second cluster, resembling the A. 
tumefaciens virD operon, codes for the TraJ T4CP and the Dtr processing factors.    
 While the pKM101 T4SS efficiently transfers pKM101 and IncQ plasmid substrates to 
E. coli recipient cells, no studies have yet examined whether this system also translocates 
protein substrates.  Here, I tested whether the native pKM101 system mediates transfer of 
known protein substrates of the A. tumefaciens VirB/VirD4 T4SS as well as known or 
putative substrates of Rickettsial VirB T4SSs.  The A. tumefaciens substrates included three 
well-characterized effectors, VirE2, VirE3, and VirF, which are delivered to plant cells during 
the course of infection.  The Rickettsial substrates included A. phagocytophilum Ats-1, which 
is translocated into mammalian cells during infection, and several other proteins whose 
T4SS-mediated translocation has been postulated on the basis of sequence composition or 
phenotypes detected from production of the Rickettsial proteins in yeast.  
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 A second goal of these studies was to test whether chimeric systems derived from 
the pKM101 T4SS function to mediate transfer of DNA or protein substrates.  Specifically, I 
substituted the T4CPs from A. tumefaciens or Rickettsial T4SSs for pKM101-encoded TraJ 
and tested whether the resulting chimeric systems would translocate the IncQ plasmid or the 
respective A. tumefaciens or Rickettsial protein substrates.  Earlier studies established a 
precedent for the functionality of chimeric T4SSs composed of a T4CP from one system and 
the channel subunits from a second [23, 61].  For example, substitution of the R388 T4CP 
TrwB, with TraG from plasmid RP4, was shown to restore mobilization of RSF1010 by a 
mutant of R388 defective for substrate transfer [23].  It is noteworthy that each of these 
chimeric systems was assayed only for their capacity to translocate DNA substrates.  My 
studies were the first to test whether chimeric conjugation machines are capable of 
translocating protein substrates. 
 
Results 
 
The pKM101 conjugative T4SS transfers non-cognate proteins 
 I assayed for the capacity of the pKM101 T4SS to translocate heterologous protein 
substrates with the Cre recombinase Reporter Assay for Translocation (CRAfT).  This assay 
has been used previously to demonstrate effector protein translocation through the A. 
tumefaciens VirB/VirD4 T4SS to yeast or plant cells, and the Legionella pneumophila 
Dot/Icm T4SS to other bacterial cells [33, 65, 66].  As shown in Figure 4.1, I expressed 
genes encoding the Cre-effector fusions from an arabinose inducible PBAD promoter in E.coli 
donor strain MS411.  The recipient, CSH26Cm::LTL (pBBR1MCS2-Genr), contains the cat 
gene, interrupted by a tetr gene that is flanked by loxP sites.  Upon translocation of the Cre-
effector fusion protein into the recipient cell, Cre recombination at the loxP sites excises the 
tetr gene, resulting in a Camr, Tets phenotype.  In these studies, recombinants were routinely 
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tested for Tets by patching the colonies onto an LB plate containing 20 µg/ml of tetracycline.  
On numerous occasions, colonies displayed a partial TetS phenotype where individual 
colonies would arise within the patch, as opposed to solid growth of the patch, which would 
indicate Tetr.  We postulate that this partial sensitivity is due to Cre-mediated recombination 
occurring during a point in cell division where two alleles are present within the cell and only 
one allele is recombined. 
 Donor cells expressed genes for the Cre-effector fusion from pBAD33, which is also 
Camr.  Therefore, to discriminate recipients in which the lox cassette had been excised from 
donor cells, it was necessary to introduce additional resistance markers into the recipient.  
Initially, I used the broad-host range vector, pBBR1MCS2-Genr, in the recipient and selected 
for Cre-effector protein transfer by plating the mating mix on chloramphenicol and 
gentamicin.  However, this approach proved problematic for the following reason.  In these 
matings, donor cells potentially translocate not only the Cre-effector protein, but also 
pKM101 at high efficiencies, to recipient cells.  Once in the recipient cell, pKM101 
elaborates a T4SS, which I found to be capable of mobilizing the transfer of pBBR1MCS2-
Genr back into donor cells, thus enabling donor cells to grow on Cam- and Gen-containing 
plates.  
pBBR1MCS2-Genr has a mobilization region from an IncP plasmid and no studies to 
date have shown that pKM101 is capable of recognizing and translocating a mobile element 
with an IncP origin-of-transfer [67, 68].  This discovery, while interesting, necessitated 
introduction of alternative resistance markers into the recipient strain for selection of lox 
cassette excisants.  A suitable recipient was generated through selection of a rifampin 
resistant (Rifr) recipient by plating dense cell cultures on LB plates containing rifampicin 
followed by introduction of the non-mobilizable plasmid pUC4K, which codes for resistance 
to carbenicillin and kanamycin.  The Kanr/Crbr/Rifr strains were tested for their capacity to 
function as recipients for uptake of pKM101-Spcr as well pML122.   While the use of the Rifr 
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recipient did not change the overall conclusions drawn from the experiments, it did provide 
less background and therefore cleaner data.  
 I constructed plasmids expressing genes for the Cre-effector fusion proteins from the 
PBAD promoter, and a plasmid encoding Cre alone as a control.  As mentioned above, I 
tested for Cre translocation mediated by effectors from A. tumefaciens (VirE2, VirE3, VirF) 
and A. phagocytophilum (Ats-1, Ats-1 CTD – the C-terminal 100 residues of Ats-1that 
presumptively carries the C-terminal signal sequence).  Transfer of the A. tumefaciens 
effectors has been shown by CRAfT [5, 65], and Ats-1 was initially identified as a VirD4Ap 
binding partner with a bacterial two-hybrid system and subsequently identified in the 
cytoplasms of infected mammalian cells [46].  I tested for the ability of the C-terminus of Ats-
1 to mediate Cre translocation because it bears features such as clusters of basic amino 
acids and a net positive charge identified among translocation signals carried by the A. 
tumefaciens T4SS effectors [46]. Additionally, I tested for Cre translocation by fusion to A. 
phagocytophilum Aph_0111.  Aph_0111 is a putative substrate provided by our collaborator, 
Dr. Jason Carlyon, and is annotated as an uridylate kinase (personal communication).  I 
also assayed for translocation of several Wolbachia putative effectors provided by a second 
collaborator, Dr. Irene Newton (personal communication). These effectors were identified in 
a high-throughput screen for proteins that induce phenotypic changes such as cell death or 
morphological changes when produced in yeast cells.  The candidate effectors include the 
ankyrin repeat containing protein, WD0636, and two annotated hypothetical proteins 
WD0811 and WD0830. 
 I first tested for production of the Cre-effector proteins in E. coli donor cells. Cells 
were induced for synthesis of the Cre-effector proteins as described in the Materials and 
Methods, and total cellular proteins were analyzed for accumulation of the fusion proteins by 
SDS-PAGE, western transfer, and development of the immunoblots with commercially 
available anti-Cre antibodies (Novus Biologicals).  As shown in Figure 4.2, most of the 
	  	   55	  
fusion proteins were detected in the cell lysates, with the exception of WD0830.  Several of 
the fusion proteins migrated aberrantly in protein gels, as judged from their predicted 
molecular sizes.  This could be due to intrinsically stable folds or extended structures that 
impeded mobility of the fusion protein through the polyacrylamide gels. Regardless, by 
immunostaining, I gained evidence that most of the Cre-effector fusions accumulated to 
detectable levels upon arabinose induction of the E. coli host cells.   
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Figure 4.1  Interbacterial protein translocation by the pKM101 T4SS  
The Cre-Recombinase Assay for Translocation (CRAfT) was used to monitor interbacterial 
protein transfer.  Translocation of the Cre-effector fusion protein, from a donor bacterial cell 
containing the pKM101 encoded T4SS is measured by excision of a gene conferring 
tetracycline resistance (Tetr) and a transcriptional terminator (term) that is flanked by loxP 
sites on the chromosome of E. coli recipient strain CSH26Cm::LTL.  Bacteria harboring the 
intact reporter are Tetr and Cams.  Cre-mediated recombination at the loxP sites allows full 
read-through of the cat gene, resulting in a Tets, Camr phenotype.   Plasmids shown are 
pKM101, pBAD33-Cre-X, where X is a translocated effector protein; and pBBR1MSC2-Genr 
(included in the recipient to aid in selection of recombinants 
pKM101 Cre-x 
Donor Recipient 
loxP loxP 
cat cat Tetr 
term 
pBBR1MCS2 pBAD33-
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Figure 4.2  Detection of Cre-effector fusion proteins in E. coli cells  
Western blot analysis of Cre-effector fusion proteins produced in E. coli donor cells without 
and with induction using 0.2% arabinose were detected by immunostaining of blots with anti-
Cre antibodies and anti-HRP secondary antibodies as described in the Materials and 
Methods.  Putative fusion proteins are shown by white arrows and Cre is indicated by a 
black arrow. 
A. Detection of Cre only and Cre fused to the A. tumefaciens effector proteins shown. 
B. Detection of Cre fused to the putative A. phagocytophilum effectors indicated.  CTD, 
Cre fused to the C-terminal domain (CTD) of Ats-1 comprised of the last 100 
residues; the gene encoding the putative Aph_0111 effector was provided by Jason 
Carlyon. 
C. Detection of Cre fused to putative Wolbachia effector proteins; the WD effector 
genes were provided by Irene Newton.  
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Interestingly, all of the tested Cre-effector fusion proteins were translocated to 
recipient cells at detectable frequencies, as monitored by CRAfT (Figure 4.3).  Effectors Ats-
1 CTD and Aph_0111 transferred below the threshold with the original recipient (Figure 
4.3A), but transferred into the Rifr recipient above the Cre-alone control at statistically 
significant levels (Figure 4.3B).  This further emphasizes the superiority of the Rifr recipient 
in accurately distinguishing genuine effector translocation.  Translocation required arabinose 
induction of the Cre-effector proteins and, furthermore, the donor strains and the recipient 
strain failed to form colonies on plates selective for the recombinants.  The recipient-only 
control was especially important, since it has been reported that lox cassettes can 
spontaneously excise as a result of homologous recombination.  I did observe that 
sequential subculturing of the recipient strain, CSH26Cm::LTL, from a frozen stock, 
occasionally yielded Camr, Tets colonies, presumably as a result of homologous 
recombination at the lox sites.  However, by routinely growing recipients freshly from the -
80oC stock, growth of the recipient-only on plates selective for recombinants was rarely 
detected.  
As reported previously for other T4SSs [33, 65], I observed Cre translocation at very 
low frequencies through the pKM101 T4SS independent of fusion to an effector protein. 
However, Cre transfer was detected only in a few of the many repetitions of these 
experiments, and in these cases only at frequencies in the range of ≤10-7 Recombinants per 
donor (Rc’s/D) when using the original recipient and ~10-8 Rc/D when using the Rifr 
recipient.  This low frequency of transfer establishes a threshold above which translocation 
of Cre was considered to be mediated by the fused effector protein.  Finally, as discussed 
below, I collaborated with another graduate student, Jay Gordon, to generate a nonpolar 
traJ deletion in pKM101.  As expected, donor cells carrying pKM101ΔtraJ failed to 
conjugatively transfer DNA substrates, and also failed to translocate the Cre-effector 
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proteins to recipient cells at detectable frequencies (Figure 4.3A).  These findings 
established the requirement for an intact pKM101-encoded T4SS for translocation. 
 The tested effector proteins mediated Cre transfer at frequencies ranging from 1.65 x 
10-6 to 8 x 10-9 recombinants per donor (Rc’s/D) (Figure 4.3B). The A. phagocytophilum 
effector Ats-1 mediated Cre transfer at the highest observed frequency of 1.65 x 10-6 Rc’s/D, 
the A. tumefaciens effector VirE2 mediated Cre transfer at the lowest observed frequency, 
and most of the other tested effectors mediated Cre transfer at frequencies of 10-7 – 10-8 
Rc’s/D.  This variation in transfer frequency could reflect biologically relevant differences in 
translocation efficiencies of the different effectors, or be attributable to differences in 
stabilities of the fusion proteins or their capacities to engage productively with the 
heterologous pKM101-encoded T4SS.  Additionally, it is important to note that Nathan 
Rosenthal performed CRAfT experiments using the Rifr recipient, whereas I performed the 
experiments with the original recipient.   While Dr. Christie or myself closely supervised Mr. 
Rosenthal and verified his data, any deviations from protocol may have further added to 
variance within and between experiments. 
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Figure 4.3 Translocation of heterologous T4SS substrates through the pKM101 
transfer system.   
Known and putative effector genes were fused to cre, and pKM101 dependent protein 
translocation into an E. coli recipient was determined by monitoring Cre-mediated excision 
of a Tetr gene as described in the Materials and Methods.   
A. Translocation of Cre-effector fusion proteins into recipient CSH26Cm::LTL containing 
the plasmid pBBR1MCS2-Genr.  Black bars, transfer by wild type pKM101 with mean 
excision frequency and standard deviations shown; White bar, transfer by 
pKM101ΔtraJ.  Experiments were performed at least 3 times.  The dashed line 
indicates the threshold of Cre-only background transfer.  ** Excision frequency is 
statistically significant from the Cre-only control (P<0.0001)  * Excision frequency is 
statistically significant from the Cre-only control (P<0.05) 
B. Translocation of Cre-effector fusion proteins by the wild-type pKM101 system into 
the recipient CSH26Cm::LTL, rifr(pUC4K).  Experiments were performed at least 3 
times.  Cre alone transfer was undetectable using this recipient due to elimination of 
any retroactive transfer.  ** Excision frequency is statistically significant from the Cre-
only control (P<0.0001) 
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trans-expression of traJ confers elevated substrate transfer 
 As mentioned above, to confirm that the pKM101 T4SS was responsible for 
mediating protein translocation, I constructed and tested the effect of a traJ deletion on 
substrate transfer.  traJ encodes the T4CP, which functions to link substrates with the 
pKM101 transfer channel.  In collaboration with another graduate student, Jay Gordon, a 
precisely deletion of traJ was generated by recombineering [51, 53].  This technique exploits 
the homologous Red recombination system of bacteriophage λ, which can catalyze 
recombination between a linear DNA fragment and a sequence of interest with as few as 25 
bp’s of homology.  Once the traJ deletion mutation (ΔtraJ) was confirmed, I first assayed for 
effects on DNA substrate transfer.  As shown in Figure 4.4, the pKM101ΔtraJ donor strain 
failed to conjugatively transfer the mutant plasmid and an isogenic strain also carrying the 
IncQ plasmid, pML122, similarly failed to mobilize IncQ plasmid transfer at detectable 
frequencies.  To ensure that the ΔtraJ mutation did not exert polar effects on expression of 
downstream genes, I expressed the wild-type traJ gene from the PBAD promoter carried on 
plasmid pBAD24-Kanr.  The complemented donor strains induced for traJ expression 
efficiently transferred both the pKM101ΔtraJ and pML122 plasmids, whereas uninduced 
cells transferred these plasmids at detectable but very low frequencies (data not shown). 
Recently, Dr. N. Whitaker showed that arabinose induction was required for detection of His-
tagged TraJ in membrane extracts of these donor strains by western blotting and 
immunostaining with anti-His antibodies, and that presence of the N-terminal His-tag does 
not hinder transfer of the pKM101 derivative or pML122 upon induction (data not shown).    
Taken together, the above findings establish that synthesis of TraJ is essential for 
plasmid transfer through the pKM101 T4SS.  Interestingly, arabinose-induction of traJ from 
pBAD24-Kanr consistently yielded transfer of both pKM101ΔtraJ and pML122 at frequencies 
of ~1 order of magnitude higher than observed with wild-type pKM101 (Figure 4.4).  While I 
was unable to directly compare steady-state levels of TraJ produced from the PBAD promoter 
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and its native promoter, I suspect that synthesis from the strong PBAD promoter yielded 
higher amounts of TraJ than from pKM101.  If so, synthesis of the TraJ substrate receptor 
for the pKM101 T4SS might be a rate-limiting step in the process of conjugative DNA 
transfer. 
I next tested whether trans-expression of traJ in a pKM101ΔtraJ donor strain 
supported transfer of the Cre-effector fusion proteins. Interestingly, several of the fusion 
proteins transferred at considerably higher levels than observed with the native pKM101 
system (Figure 4.5).  Most strikingly, donor strains translocated the WD0811 and WD0830 
fusion proteins at frequencies nearly 10-5 and 10-4 Rc’s/D, respectively, as monitored by 
CRAfT.  Donor strains producing the other fusion proteins also exhibited elevated transfer 
frequencies compared with the wild-type system.  Additionally, when Nathan Rosenthal 
used the Rifr recipient in recent experiments, translocation of most effectors was detected at 
approximately 10-6 to 10-4 Rc’s/D with transfer of Cre alone reduced to 1.0 x 10-8 Rc’s/D.  Of 
further interest, translocation of Cre alone occurred at a frequency slightly above that 
observed with the wild-type system with both recipients.  Nevertheless, the transfer 
frequency of Cre alone remained considerably less than those of the Cre-effector fusion 
proteins.  Based on these findings, I propose that trans-expression of traJ from the strong 
PBAD promoter on multicopy pBAD24-Kanr confers elevated transfer of both DNA and protein 
substrates through the pKM101 transfer channel.   
Finally, it should be noted that although I detected translocation of the Cre-VirE2 
fusion protein, previous work has shown that VirE2 requires its secretion chaperone VirE1 
for translocation through the A. tumefaciens VirB/VirD4 T4SS.  VirE1 is not required for 
substrate docking with VirD4 but instead prevents VirE2 from self-aggregating.  In future 
studies, it will be of interest to determine if VirE1 coproduction confers Cre-VirE2 
translocation in the pKM101 system at higher frequencies than observed in the present 
studies.   
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Figure 4.4  Effects of a pKM101 traJ deletion and complementation with heterologous 
virD4 genes on DNA substrate transfer.  
E. coli donor cells carrying pKM101 or pKM101ΔtraJ lacking or expressing the genes 
indicated were tested for pKM101 transfer and mobilization of the IncQ plasmid, pML122, to 
E. coli recipients.  Transfer frequencies are reported as transconjugants per donor.  
Experiments were repeated at least 2 times in duplicate and the mean transfer frequencies 
with standard deviations are shown.  WT, pKM101; ΔtraJ, pKM101 deleted of traJ, and 
ΔtraJ expressing traJ and virD4 homologs.  * Substrate transfer was statistically significant 
from wild-type. 
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Figure 4.5  Transfer of heterologous T4SS substrates through the E. coli  pKM101 
transfer system.  Protein transfer was performed as described in Materials and Methods by 
using E. coli containing pKM101ΔtraJ and plasmids expressing cre fusions and traJ.  Cre 
only was used as a negative control, with the dashed line indicating the threshold of Cre 
background transfer.  
A. Translocation of Cre-effector fusion proteins into recipient CSH26Cm::LTL containing 
the plasmid pBBR1MCS2-Genr.  Experiments were repeated at least 2 times in 
duplicate with the mean excision frequency and standard deviations shown.   
* Excision frequency is statistically significant from the Cre alone control (P<0.05) 
B. Translocation of Cre-effector fusion proteins by the pKM101 system expressing traJ 
from the multicopy plasmid, pBAD24-Kanr, into the recipient CSH26Cm::LTL, 
rifr(pUC4K).  Experiments were repeated at least 2 times.  ** Excision frequency is 
statistically significant from the Cre alone control (P<0.0001) 
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Do heterologous T4CPs functionally substitute for TraJ in mediating DNA transfer 
through the pKM101 transfer system? 
 In Chapter 3, I determined that the Rickettsia VirD4 homologs did not functionally 
substitute for VirD4At in A. tumefaciens.  Although these T4CPs might be unstable or fail to 
interact productively with the A. tumefaciens VirB channel, it is also possible that the A. 
tumefaciens VirB/VirD4 T4SS does not mediate transfer of substrates to other agrobacteria 
at frequencies sufficient for detecting functionality of the swapped T4CPs.  By contrast, the 
highly efficient pKM101 system, supporting plasmid transfer at frequencies exceeding 1 
Tc/D, might be sufficient for detection of low-frequency substrate transfer.  To test this idea, I 
asked whether the VirD4 T4CPs from A. tumefaciens or the Rickettsial species functionally 
substituted for TraJ.  
 I expressed the virD4 genes from A. tumefaciens and W. pipientis from a PBAD 
promoter carried on pBAD24 in donor strains carrying pKM101ΔtraJ.  Perhaps not 
surprisingly, I was not able to detect complementation of the ΔtraJ mutation as monitored by 
transfer of pKM101ΔtraJ (Figure 4.4).  I next tested for the capacity of isogenic donors for 
mobilization of the IncQ plasmid pML122, but again I was unable to detect plasmid transfer 
(Figure 4.4).  It is important to note that, although there is no evidence for IncQ plasmid 
transfer by the native T4SSs carried by W. pipientis, the A. tumefaciens VirB/VirD4 T4SS 
mobilizes the transfer of the IncQ plasmid to agrobacterial recipients.  In view of these 
findings, I envision two possibilities for the failure of the heterologous T4CPs to substitute for 
TraJ.  First, these T4CPs might be unstable in the E. coli donor cells.  Second, they might 
fail to interact productively with the pKM101-encoded transfer channel.  I examine the 
second possibility in more detail in Chapter 5 of this thesis.  To address the first possibility, 
Dr. N. Whitaker is currently adding His-tags to the heterologous T4CPs to evaluate their 
steady-state abundance in arabinose-induced donor cells by western blot analysis.  
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In view of my finding above that trans-expression of the Rickettsial T4CPs in wild-
type A. tumefaciens conferred diminished substrate transfer through the VirB/VirD4 T4SS, I 
tested for poisoning interactions of the heterologous T4CP on functionality of the native 
pKM101 T4SS.  Interestingly, production of VirD4 subunits from A. tumefaciens or the 
Rickettsial species did not abrogate transfer of pKM101ΔtraJ to recipients (Figure 4.6). 
These findings are consistent with the proposal that the heterologous T4CPs fail to interact 
with the pKM101 T4SS. 
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Figure 4.6.  Effects of trans-expressed traJ and virD4 homologs on wild type pKM101 
self-transfer   
 E. coli donor cells carrying pKM101 and expressing the genes indicated were tested for 
pKM101 transfer to E. coli recipients.  Transfer frequencies are reported as transconjugants 
per donor.  Experiments were repeated at least 3 times in duplicate and the mean transfer 
frequencies with standard deviations are shown. WT, pKM101 lacking (-) or expressing the 
virD4 homologs shown. 
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Do heterologous T4CPs functionally substitute for TraJ in mediating protein transfer 
through the pKM101 transfer system? 
 To further assess the functionality of the chimeric T4SSs, I assayed for translocation 
of effector proteins.  Specifically, I tested for translocation of the Cre::Ats-1 fusion protein by 
donor strains producing the VirD4 T4CPs from A. tumefaciens and the Rickettsial homologs.  
Ats-1 was chosen as a test substrate because it consistently transferred at high levels 
without much variation, whereas other Cre-effector fusions showed greater inconsistency 
between experiments.  The chimeric T4SSs were also assayed for transfer of Cre alone as 
a control. 
 As shown in Figure 4.7, pKM101ΔtraJ-carrying donor cells engineered to produce 
the VirD4Ap T4CP transferred the Cre::Ats-1 fusion protein at frequencies only slightly lower 
than the isogenic donors producing native TraJ.  This donor did not translocate Cre alone at 
detectable frequencies. The VirD4Ap T4CP is thus capable of engaging productively with the 
pKM101-encoded T4SS to mediate translocation of the cognate Ats-1 effector to E. coli 
recipient cells.  These findings established that Ats-1 engages productively with two 
heterologous T4CPs, TraJ and VirD4Ap, in E. coli.  I next tested whether the donor cells 
producing other T4CPs, including those from A. tumefaciens, W. pipientis, and R. rickettsii 
mediated Ats-1 transfer (Figure 4.7).  These donors failed to transfer the Ats-1 fusion protein 
at detectable levels.  
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Figure 4.7  Cre-mediated transfer of Anaplasma effector protein Ats-1 through 
pKM101-based chimeric T4SSs 
Transfer of Anaplasma T4SS substrate Ats-1 between bacterial cells.  Ats-1 Transfer of Cre 
fused to Ats-1 by donor E. coli cells carrying pKM101ΔtraJ and expressing virD4 genes from 
A. tumefaciens and Rickettsial species was monitored by Cre-mediated excision of a TetR 
gene as described in Materials and Methods. Cre-only was used as a negative control.  
Experiments were repeated at least 2 times with mean excision frequencies and standard 
deviations shown.  * Excision frequency was statistically significant from the Cre-only control 
(P<0.0001) 
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Discussion 
 
The TraJ T4CP is essential and rating limiting for pKM101 and IncQ plasmid transfer. 
 The conjugative plasmid pKM101 has long been known to transfer itself between E. 
coli cells via a T4SS similar to that of the VirB/VirD4 system of A. tumefaciens.  This transfer 
is mediated by interactions of VirD4-like TraJ, with the relaxasome components [43, 64, 69]. 
This was confirmed with the creation of a clean deletion mutant of traJ in pKM101, which 
was found to completely abolish conjugal transfer of the plasmid.  Importantly, this mutant 
could be complemented with trans-expressed traJ, indicating the deletion had no polar 
effects on the remainder of the Tra operon.  In addition to conjugative self-transfer, I 
determined that the T4SS of pKM101 also mobilizes the IncQ plasmid, pML122.  Even with 
lower frequency of transfer at 10-2-10-3 Tc/D for an overnight mating, this is a novel substrate 
of this system. Furthermore, I showed that transfer of IncQ is TraJ-dependent, since IncQ 
transfer was also completely abolished in pKM101ΔtraJ. 
 
Protein translocation through the conjugative T4SS of pKM101: a novel finding 
 The T4SS encoded on plasmid pKM101 has been sequenced in its entirely [64], and 
to date no proteins have been shown to be translocated through this system exclusive of 
relaxasome components in complex with DNA.  Although the interactions between coupling 
proteins and relaxasome components have been shown to be very system specific [9], 
interactions with protein effectors seem to be less specific as shown by transfer of 
heterologous proteins through the pKM101 system.  Based on these findings, it is possible 
that the T4CPs of the T4SSs recognize general features of protein substrates such as C-
terminal hydrophobic tails or clusters of positively charged residues, or internal motifs of 
unspecified sequence composition or secondary structure. 
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 Previous studies have identified potential signal sequences in the C-terminal 50 
residues of some effectors.  Specifically, Vergunst, et al. demonstrated in 2000 that the C-
terminal 37 residues of VirF in A. tumefaciens were sufficient for translocation into recipient 
cells indicating the possible presence of a transport signal [5].  Further comparison with the 
amino acid sequence of the effector VirE2, revealed a conserved R-P-R motif in this region.  
Another study showed that the C-terminal 50 residues of VirE2 and VirE3 were sufficient for 
effective transfer using the CRAfT assay [65], providing further support of a C-terminal 
transport signal.  Later studies of these C-terminal regions identified the C-terminal 19 
amino acids to be adequate for transfer of VirF, and identified a consensus sequence of R-
X(7)-R-X-R-X-R-X-X(n)> upon comparison to other effectors [66]. 
 Examination of the C-terminal regions of the effectors presented in this thesis 
indicated that the R-P-R or R-X(7)-R-X-R-X-R-X-X(n)> signal sequences previously 
identified were not present in the Anaplasma or Wolbachia effectors (Figure 4.8A).  Previous 
examination of the Ats-1 C-terminal 20 residues revealed a greater abundance of positively 
charged residues relative to the remainder of the protein [46].  Indeed, examination of the C-
terminal 30 residues yielded a net positive charge of +1.2 at pH 7.0 for Ats-1, while 
Aph_0111, WD0636, and WD0830 all had net charges of -0.1.  WD0811 yielded a net 
positive charge of +2.2 in this region (Figure 4.8B).   
While positively charged residues in the C-termini have been shown to be important 
for substrate recognition, other factors must also be necessary.  As demonstrated above, 
expression of Ats-1 CTD yielded consistently less transfer than full-length Ats-1 through the 
native pKM101 system, suggesting that other domains may be necessary for efficient 
transfer through this heterologous system.  Similarly, WD0636 and WD0830 transferred at 
rates similar to effectors carrying charged C-termini, indicating these effectors are using 
another means of recognition.  As shown above, sequence alignment and analysis of the C-
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terminal 30 residues does not reveal any conserved sequence or motif among these 
proteins. 
 In Chapter 3, I hypothesized that the CTE of VirD4At played a role in recognition of 
effector proteins, since deletion of the CTE allowed transfer of IncQ but abolished plant 
tumorgenesis.  Additionally, I suggested that conjugation T4SSs such as pKM101 do not 
have a CTE because they translocate DNA but not protein substrates.  However, the finding 
that TraJ is able to transfer heterologous proteins in the absence of a CTE, indicates that 
translocation of these proteins is not dependent on interaction with a C-terminal extension.  
It is possible that CTE’s carried by other T4CPs play a modulatory role, such as mediating 
transfer of specific substrates, enhancing transfer of some substrates by promoting 
substrate-T4CP contacts or coordinating the timing of transfer of numerous substrates 
through a T4SS. The function of the CTE is addressed further in Chapter 5. 
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Figure 4.8  Analysis of the effector C-terminal tails 
A. Sequence alignment of the C-terminal 30 residues of the A. tumefaciens effectors 
VirE2, VirE3, and VirF indicating a conserved R-P-R motif (top), and the Anaplasma 
and Wolbachia effectors presented in this thesis (below).  Alignment of the 
Rickettsial effectors show the R-P-R or R-X(7)-R-X-R-X-R-X-X)n> signal sequences 
previously identified are not present in these effectors. 
B. C-terminal 20 residues of the A. tumefaciens and Rickettsial effectors.  Positively 
charged residues are identified in bold print, while hydrophodic residues are 
underlined.  Overall charge and pI of the protein fragment are indicated. 
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A 
B 
Effector Sequence Charge pI 
VirE2! ISDSRRIYESRPRSQSVNSF ! +2.9! 11.31!
VirE3! ARSMIFEGSRPRERSTSRGF ! +4.9! 11.83!
VirF! HDDARAELMSADRPRSTRGL ! +3.2! 11.31!
Ats-1! VTPLVSAQNRGPETHGKGTR ! +1.2! 9.06!
Aph_0111! KENAFSEVMKGRGTFTTISG ! -0.1! 6.25!
WD0636! EVTEVLKKETDRIEKLFEKL ! -0.1! 6.62!
WD0811! QIRGGTTLKRVGSNKILQMN ! +2.2! 10.00!
WD0830! LDQPSAEPVNSRATATPGTV ! -0.1! 6.25!
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A chimeric T4SS composed of homologous T4CPs and the pKM101 encoded mating 
channel 
 It has been shown that T4CPs are able to form stable interactions with channel 
subunits from non-cognate T4SS [9], and that they are able to interact with and transfer non-
cognate protein effectors into target cells [22].  Therefore, we wanted to explore the use of 
pKM101 as a chimeric T4SS for the transfer of DNA and protein substrates.  Genes 
encoding full-length coupling proteins from either A. tumefaciens or Wolbachia were 
expressed in E. coli containing pKM101ΔtraJ.  These homologous T4CPs failed to support 
transfer of pKM101 or the IncQ plasmid.  As mentioned above, pKM101 is not a natural 
substrate for the A. tumefaciens or Wolbachia T4SSs, although the A. tumefaciens system 
does transfer the IncQ plasmid to other agrobacteria.  The lack of transfer of any DNA 
substrate by the chimeric T4SSs could be due to instabilities of the T4CPs in E. coli, or a 
failure to engage properly with the pKM101-encoded secretion channel.  Recall that in the A. 
tumefaciens VirB/VirD4 system, the Rickettsial T4CP genes conferred negative dominance 
when expressed in wild-type strain A348, suggesting that the T4CPs somehow poison 
substrate transfer through the VirB/VirD4 T4SS.  In the E. coli pKM101 system, expression 
of the heterologous T4CPs did not exert negative dominance.  From these experiments, no 
conclusions can be drawn regarding the capacity of the heterologous T4CPs to engage 
productively or nonproductively with the pKM101 system or its DNA substrates.  In the next 
chapter, however, I describe results of experiments showing that the heterologous T4CPs in 
fact can function to mediate substrate transfer when their N-terminal transmembrane 
domains are substituted with that of TraJ.  
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Chapter 5.  The Development of Chimeric Coupling Proteins in an Effort to Enhance 
Substrate Transfer Through a Surrogate T4SS 
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Introduction 
 The Tra type IV secretion system of pKM101 translocates DNA substrates including 
pKM101 and mobilizable IncQ plasmids to other bacterial cells through a process requiring 
direct cell-cell contact [43].  This transfer system consists of a secretion channel and the 
type IV coupling protein (T4CP) termed TraJ, the latter of which physically joins secretion 
substrates to the transfer channel.  Previous studies have shown that some T4CPs can be 
substituted for another and mediate transfer of IncQ plasmids through the heterologous 
T4CP [9, 23]. As reported in Chapter 4, substitution of A. phagocytophilum VirD4 for 
pKM101-encoded TraJ supported translocation of the effector protein Ats-1 through the 
pKM101 secretion channel.  However, I was unable to create chimeric systems capable of 
mediating DNA transfer by substituting Rickettsial T4CPs for VirD4 in the A. tumefaciens 
system or heterologous T4CPs for TraJ in the E. coli pKM101 system.  
 As mentioned earlier, the T4CPs are composed of several distinct domains, the N-
terminal transmembrane domain (TMD), nucleotide binding domain (NBD), all-alpha domain 
(AAD), and in some cases a C-terminal extension (CTE).  There is some evidence that the 
TMDs mediate interactions of T4CPs with one or more subunits of the transfer channel, 
whereas one or more of the other domains mediate interactions with secretion substrates [9, 
12, 23, 45, 70-73].  I thus hypothesized that the failure of the Rickettsial and A. tumefaciens 
T4CPs to mediate substrate transfer through the pKM101 translocation system is due to the 
inability of the respective TMDs to engage productively with the pKM101 channel subunits.  
To test this hypothesis, I asked whether chimeric coupling proteins composed of the TMD of 
TraJ and the remaining domains from the A. tumefaciens or Rickettsial T4CPs would 
mediate substrate transfer (Figure 5.1).    
 Overall, this line of study was intended to: i) test whether the TMD mediates the 
T4CP-channel interaction, ii) enhance the efficiency of heterologous protein substrate 
transfer through the pKM101 transfer system over that achieved with the native pKM101 
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system, and iii) test the importance of the C-terminal domain of A. tumefaciens VirD4 for 
recognition of A. tumefaciens protein substrates.  My work also was intended to generate 
the molecular tools necessary for longer-term studies aimed at testing whether chimeric 
systems can be used to identify novel protein substrates of the Rickettsial VirB/VirD4 T4SSs 
that fail to translocate through the native pKM101 system.  
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Figure 5.1  Schematic of chimeric coupling proteins 
Diagram illustrating the domain organization of the different chimeras.  The TMD of TraJ is 
represented on the left in yellow, with the various soluble domains on the right.  The 
numbers represent the amino acid residue at the beginning or end of the domain.  The 
different domains are identified at the top:  TMD, trans-membrane domain; AAD, all-alpha 
domain; NBD, nucleotide binding domain; CTE, C-terminal extension. 
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Results 
 
DNA substrate transfer using chimeric coupling proteins 
Chimeric proteins were constructed by combining the TMD of TraJ with the SD of 
another VirD4-like coupling protein.  Dr. N. Whitaker created two chimeras by joining the 
TraJ TMD with the A. tumefaciens VirD4 soluble domain (SD).  Plasmid pNW2 expresses a 
gene encoding TraJ::VirD4At and pNW4 expresses a gene encoding TraJ::VirD4AtΔ553, 
which is deleted of VirD4’s C-terminal extension (Table 2.1, Figure 5.1).  Upon expression of 
both chimeric genes in pKM101ΔtraJ, conjugative transfer of pKM101 was not detected 
(Figure 5.2).  However, we did observe mobilization of the IncQ plasmid at frequencies 
slightly below those observed for IncQ plasmid transfer by wild type pKM101.  Dr. Whitaker 
also made a TraJ::VirD4At chimera deleted of its AAD (TraJ::VirD4AtΔAAD; pNW6), and this 
chimera was not able to translocate pKM101 or the IncQ plasmid.  These findings establish 
that the TraJ::VirD4At chimera is fully functional for translocation of the promiscuous IncQ 
plasmid.  Furthermore, VirD4At’s SD is not capable of engaging or delivering the pKM101 
substrate through the translocation channel.  Finally, as reported with the A. tumefaciens 
system, VirD4At’s CTE is not important for IncQ plasmid transfer to recipient bacteria.  By 
contrast, the AAD is essential for all plasmid substrate transfer. 
I followed this up by creating chimeric coupling proteins containing the SDs of 
Rickettsial homologs (Table 2.1, Figure 5.1).  TraJ::VirD4Ap  (pTB39) and TraJ::VirD4Wp 
(pTB51) were tested for their ability to mediate pKM101 and IncQ plasmid transfer through 
the VirB channel. As shown in Figure 5.2, neither chimera supported DNA substrate 
transfer, indicating that the SDs of these chimeric proteins do not engage productively with 
or deliver the DNA substrates to the transfer channel.  Another possibility is these chimeric 
proteins are unstable in E. coli.  
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Figure 5.2  Conjugative transfer of pKM101 and the IncQ plasmid pML122 between E. 
coli cells  
Conjugative transfer mediated by T4SSs composed of the pKM101-encoded transfer 
channel and traJ or chimeric coupling proteins. Deletion of the all-alpha domain (AAD; 
residues 186-298) of TraJ or the chimeras show abolished substrate transfer.  Experiments 
were repeated at least 2 times; results are reported as mean frequency of transfer with 
standard deviations indicated. WT, pKM101; ΔtraJ, pKM101 deleted of traJ; pKM101ΔtraJ 
expressing traJ, traJΔAAD, or the indicated chimeras.  * Substrate transfer is statistically 
significant from wild-type (P<0.0001) 
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Protein effectors are translocated by the pKM101 system via a chimeric coupling 
protein 
 Next, I tested whether the chimeric T4CPs mediate transfer of effector proteins. E. 
coli strain MS411 carrying the Cre-effector expression plasmids and pKM101ΔtraJ served 
as donors and CSH26Cm:LTL(pBBR1MCS2-Genr) served as the recipient.  As shown in 
Figure 5.3, donor strains producing the TraJ::VirD4At chimeric coupling protein translocated 
the A. tumefaciens effector VirF at frequencies of 3 x 10-8 Rc’s/D, whereas the isogenic Cre-
only donor failed to translocate Cre at detectable frequencies.  Donor strains producing the 
TraJ::VirD4At  chimera failed to translocate Cre::VirE2 or Cre::VirE3 at detectable levels.   
However, in more recent work, Nathan Rosenthal in the Christie lab showed that Cre-VirE2 
was translocated at ~10-6 Rc’s/D when the secretion chaperone VirE1 was coproduced in 
the donor cells (data not shown).  These findings are consistent with previous reports 
showing that VirE1 is essential for translocation of VirE2 through the A. tumefaciens 
VirB/VirD4 T4SS. 
 The above findings prompted further tests of chimeric T4CPs composed of TraJ’s 
TMD and SDs from A. phagocytophilum and W. pipientis.  I was interested in testing 
whether codon optimization of the SD from A. phagocytophilum VirD4 enabled substrate 
transfer, and to this end I sent the TraJ::VirD4Ap chimera to Invitrogen for codon optimization 
and artificial synthesis using their GeneArt® technology.  I then generated plasmids 
expressing genes for the TraJ::VirD4Ap chimeric T4CP as well as this T4CP deleted of its C-
terminal extension designated as TraJ::VirD4ApΔ574. Donor strains carrying pKM101ΔtraJ, 
pTB39 which produces TraJ::VirD4Ap, and plasmids producing the Rickettsial effector fusion 
proteins were assayed for protein transfer by CRAfT.  Interestingly, I was able to detect 
translocation of several of the Cre-effector fusions (Figure 5.4). The Cre::Ats-1 and 
Cre::Aph_0111 fusion proteins were translocated at the highest frequencies of ~2 x 10-7 
Rc’s/D. The Cre::Ats-1 CTD and Cre::WD0811 fusion proteins were delivered to recipients 
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at frequencies of ~3 x 10-8 Rc’s/D.  Cre joined to another putative Wolbachia effector, 
WD0636, was translocated but at frequencies only slightly above background levels 
observed with Cre only.  Recent experiments using the Rifr recipient have shown that the 
Anaplasma effectors all transfer at approximately 10-7 Rc’s/D, while the Wolbachia effector 
WD0811 has transferred at frequencies approaching 10-6 Rc’s/D (data not shown).  
Additional experiments are needed to test transfer of the other substrates using this 
recipient. 
 I also tested for transfer of the Wolbachia effectors by donor cells producing the 
TraJ::VirD4Wp chimeric protein (Figure 5.5).  Transfer with this chimeric system was rather 
weak using the original recipient with Ats-1, WD0636, and WD0811 transferring at levels 
only slightly above Cre alone.  Interestingly, this chimeric system supported a much more 
robust excision frequency with the Rifr recipient, where background is nearly undetectable. 
This system was able to transfer Cre::Ats-1 and Cre::Ats-1 CTD and frequencies of ~10-6 
and Cre fused to the three Wolbachia effectors at frequencies between 10-7 and 10-6 Rc’s/D 
(data not shown).  Again, further experiments are required to test the remaining effectors 
with the Rifr recipient. 
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Figure 5.3.  Protein translocation between E. coli cells mediated by T4SSs composed 
of the pKM101-encoded transfer channel and the Tra::VirD4At T4CP. 
 A. tumefaciens effectors of the VirB/VirD4 T4SS were fused to Cre and tested for 
translocation to recipient cells carrying a lox-tetr-lox cassette, as described in Materials and 
Methods. Donor strains produced TraJ::VirD4At (black bars) or TraJ::VirD4AtΔ553 (white 
bars).  Experiments were repeated at least 2 times and results are reported as mean 
frequency of Cre-mediated excision, with standard deviations indicated.  * Excision 
frequency is statistically significant compared to the Cre-only control (P<0.0001)  ** Excision 
frequency is statistically significant with deletion of the CTE (P<0.0001) 
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Figure 5.4.   Interbacterial protein transfer using chimeric coupling proteins with the 
soluble domain from A. phagocytophilum 
T4SSs composed of the pKM101-encoded transfer channel and the Tra::VirD4Ap T4CP were 
assayed for translocation of Cre fused to putative T4SS effectors from Rickettsial species. 
Donor strains produced TraJ::VirD4AP (black bars) or TraJ::VirD4WpΔ574 (white bars).  
Experiments were repeated at least 2 times, and results are reported as mean frequency of 
Cre-mediated excision, with standard deviations indicated.  ND, experiments were not done. 
* Excision frequency is statistically significant compared to the Cre-only control (P<0.05)  ** 
Excision frequency is statistically significant with deletion of the CTE (P<0.05) 
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Figure 5.5  Interbacterial protein transfer using chimeric coupling proteins containing 
the soluble domain from W. pipientis 
T4SSs composed of the pKM101-encoded transfer channel and the Tra::VirD4Wp T4CP 
were assayed for translocation of Cre fused to putative T4SS  effectors from Rickettsial 
species. Donor strains produced TraJ::VirD4Wp (black bars) or TraJ::VirD4WpΔ574 (white 
bars).  Experiments were repeated at least 3 times, and results are reported as mean 
frequency of Cre-mediated excision, with standard deviations indicated.  * Excision 
frequency is statistically significant compared to the Cre-only control (P<0.0001)  ** Excision 
frequency is statistically significant with deletion of the CTE (P<0.0001) 
	  	   90	  
The T4CP CTE modulates effector translocation 
 As shown earlier in this thesis, in A. tumefaciens the VirD4At deleted of its CTE did 
not alter translocation of the IncQ plasmid to agrobacterial recipients but abolished T-DNA 
transfer to plants.  Similarly, in E. coli, the TraJ::VirD4At and TraJ::VirD4AtΔCTE chimeras 
supported IncQ plasmid transfer but not pKM101 through the pKM101 transfer channel.  
These findings established that VirD4’s CTE contributes to translocation of DNA substrates 
native to the cognate T4SS, but not to the promiscuous IncQ plasmids.  I next tested 
whether the CTE of VirD4At contributes to effector protein transfer.  Interestingly, although I 
did not see any effect of deleting the CTE on translocation of VirE2 or VirE3, translocation of 
VirF was dramatically enhanced (Figure 5.3).  This suggests that the CTE of VirD4At plays 
an inhibitory role in VirF translocation.   
 CTE deletions of Anaplasma and Wolbachia chimeras, TraJ::VirD4ApΔ574 and 
TraJ::VirD4WpΔ574, were also examined for  their ability to translocate the Cre-effector 
fusions.  Donor cells producing the TraJ::VirD4ApΔ574 chimera translocated the Ats-1 and 
Ats-1 CTD effectors at higher frequencies than donors producing the full-length chimera 
(Figure 5.4).  However, translocation of Aph_0111 was abolished, suggesting that the CTE 
is important for translocation of this putative effector. Donor cells producing the 
TraJ::VirD4WpΔ574 chimera failed to translocate the A. phagocytophilum effectors and also 
the Wolbachia putative effectors, with the exception of WD0811, which transferred at 
approximately the same frequency as the system composed of the TraJ::VirD4Wp chimera 
(Figure 5.5).  Experiments are still being completed to examine the effects of CTE deletion 
using the Rifr recipient.   
Taken together, results of these studies establish that the CTE of A. tumefaciens 
VirD4 contributes to translocation of cognate T-DNA substrate, and possibly effector 
proteins, to plant cells.  However, the CTE is not important for IncQ plasmid in either A. 
tumefaciens or E. coli, and in E. coli VirD4At’s CTE also negatively affects translocation of 
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the protein effector VirF.  The CTE’s of the A. phagocytophilum and W. pipientis effectors 
modulate - either positively or negatively - translocation of effector proteins.  Of particular 
interest, VirD4Ap’s CTE disrupts Ats-1 transfer, but is essential for translocation of 
Aph_0111. VirD4Wp’s CTE was shown to be required for transfer of Ats-1 and dispensable 
for transfer of WD0811, however interpretation of these results were inconclusive due to 
overall low excision frequencies.  
 
Discussion 
 
Chimeric coupling proteins retain the ability to translocate a variety of substrates in a 
surrogate T4SS 
 Although previous studies showed that chimeric T4SSs composed of a T4CP from 
one system and the channel subunits from another are functional [9, 20, 22], my work has 
shown for the first time that T4SSs composed of chimeric coupling proteins are functional. 
The goal of these studies was to determine whether such chimeric systems would support 
translocation of cognate and non-cognate substrates with higher sensitivity and higher 
efficiency than observed for the native pKM101 system.  If such a system could be 
designed, it would greatly improve our ability to identify and study substrates from 
pathogens that are known to contain T4SSs but are difficult to grow or genetically 
manipulate.  Additionally, such systems will allow for further detailed studies aimed at 
identifying specific T4CP domains of functional importance as well as motifs or domains 
required for substrate-T4CP engagement. In the previous chapters, I demonstrated that the 
pKM101 T4SS transfers known and putative substrates, including an IncQ plasmid, the A. 
phagocytophilum effector Ats-1, and other effectors from Wolbachia and A. tumefaciens.  
Here, I showed that various chimeric T4CPs supported DNA or effector protein transfer, 
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although not at levels higher than native pKM101 system or the pKM101 system 
presumptively overproducing the TraJ T4CP.   
 Fusion of TraJ’s TMD with the SD of VirD4At resulted in a chimera that supported 
transfer of the IncQ plasmid and the A. tumefaciens effector VirF.  It is noteworthy that this 
system translocated the IncQ plasmid at frequencies comparable to native pKM101, yet it 
failed to translocate pKM101 at detectable frequencies.  This suggests that VirD4At’s SD 
contains specific sequence information or a structural fold necessary for productive 
engagement with the IncQ plasmid substrate.  By contrast, this SD lacks the interaction 
domain necessary for engagement with the pKM101 substrate.  My finding that the 
TraJ::VirD4At chimera supported VirF translocation established that VirD4At’s SD also carries 
the motif necessary for engagement with this substrate.   
 VirF is not known to require a secretion chaperone for translocation through the 
VirB/VirD4 T4SS. By contrast, VirE2 requires its chaperone VirE1 and it appears that my 
inability to detect VirE2 translocation was because the donor strain used in my studies did 
not produce VirE1.  Nathan Rosenthal, a Rice University undergraduate student, 
demonstrated that VirE1 coproduction with Cre-VirE2 supported transfer of the fusion 
protein (data not shown). Together, these findings established that the TraJ::VirD4At chimera 
supports transfer of both chaperone-independent and –dependent effector proteins.   The A. 
tumefaciens VirB/VirD4 T4SS translocates T-DNA and effector proteins to yeast cells, as 
well as to plant cells as a part of the infection process.  It will be interesting in future studies 
to test whether the E. coli pKM101 system with the TraJ::VirD4At chimera also supports 
transfer of T-DNA substrates to E. coli or eukaryotic recipient cells.   
 I was also able to demonstrate translocation of Cre-effector fusion proteins through 
pKM101 systems relying on the TraJ::VirD4Ap and TraJ::VirD4Wp chimeras.  The former 
supported transfer of the A. phagocytophilum effectors in addition to WD0636 and WD0811 
from Wolbachia, whereas the latter was more rigid in its capacity to bind and mediate 
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translocation of most of the A. phagocytophilum and Wolbachia effectors.  With the 
exception of their variable CTE’s, the VirD4Ap and VirD4Wp SD’s are highly similar in overall 
sequence composition (78% identity).  As discussed further below, these observations 
suggest that the CTE’s of these T4CPs may play important roles in substrate selection and 
translocation modulation.   
 
The roles of the AAD and CTE in type IV secretion. 
 An important goal of these experiments was to assign functional importance to the 
T4CP domains.  For example, although the native T4CPs from A. tumefaciens and 
Wolbachia did not mediate translocation of any tested substrates, the corresponding 
chimeric proteins composed of the TraJ TMD joined to the SD’s of these T4CPs supported 
translocation of at least some substrates.  These findings strongly indicate that the TMD of 
TraJ is critical for productive interactions with the rest of the pKM101 transfer machinery.  
This finding is consistent with a previous study in which mutations in the TMD of R388-
encoded TrwB abolished the capacity of this T4CP to mediate DNA transfer and also 
disrupted an interaction with the VirB10-like subunit TrwE [9].   
 The functionality of the chimeric T4CPs further suggested that SD’s of the T4CP 
confer both substrate binding and specificity.  The SD’s of A. tumefaciens, A. 
phagocytophilum, and W. pipientis are composed of three smaller domains, the NBD’s, 
AAD’s, and CTE’s.  Here we have shown that the AAD’s of both TraJ and VirD4At are 
required for translocation of DNA substrates in the pKM101 system.  Dr. N. Whitaker has 
expanded this study to show this domain is also required for translocation of protein 
substrates in the pKM101 system, as well as DNA and protein substrates in the A. 
tumefaciens system (data not shown).  He has also shown that the AAD domain of VirD4At 
binds DNA and also interacts with VirE2.  These findings suggest that the AAD’s of T4CPs 
play a role in substrate binding and translocation. Interestingly, however, the AAD’s of VirD4 
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proteins from A. phagocytophilum and W. pipientis are highly similar, suggesting that these 
domains probably are not solely responsible for mediating binding of the different effectors 
translocated through these Rickettsial species.  However, the CTE’s of these proteins as 
well as the CTE of A. tumefaciens, are highly variable in sequence composition and overall 
charge.  In view of these observations, I tested a hypothesis that the T4CP CTEs contribute 
to substrate transfer. 
 TraJ::VirD4At was the only chimeric T4CP of those tested that supported DNA 
transfer through the pKM101 transfer system (Figure 5.2).  Deletion of VirD4’s CTE had no 
effect on IncQ plasmid transfer, establishing that this domain is not important for transfer of 
this promiscuous plasmid.  This conclusion is further supported by the fact that pKM101-
encoded TraJ lacks a CTE and yet transfers the IncQ plasmid at frequencies similar to that 
of donor cells producing TraJ::VirD4AtΔ533. 
 In general, deletions of the CTEs associated with VirD4At, VirD4Ap, and VirD4Wp had a 
range of effects on effector protein translocation.  For example, donor cells producing 
TraJ::VirD4AtΔ533 transferred Cre-VirF at higher frequencies than donors producing 
TraJ::VirD4At (Figure 5.3).  Similarly, cells producing the VirD4Ap chimera deleted of its CTE 
translocated the Ats-1 and Ats-1 CTD effectors at a higher frequency than cells producing 
the full-length chimera.  In view of my finding that trans-expression of traJ in a pKM101ΔtraJ 
donor conferred elevated DNA transfer frequencies compared to the native pKM101 system, 
it is formally possible that the CTEs deletions enhanced stabilities of the T4CPs and that the 
higher amounts of the chimeric T4CPs correlated with higher transfer frequencies. I suspect 
this is not the case, however, because strains producing the VirD4Ap and VirD4Wp chimeras 
with CTE deletions did not always confer elevated effector protein translocation.  For 
example, TraJ::VirD4ApΔ574 did not support translocation of the Aph_0111 putative effector 
at detectable levels. Additionally, TraJ::VirD4WpΔ574 translocated WD0811 at similar levels 
to the full-length chimera. My data suggest, therefore, that the CTEs modulate translocation 
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of effector proteins in different ways, in some cases enhancing transfer while in other cases 
impeding or completely blocking transfer.  Additional experiments are being done to explore 
the effects of CTE deletions using the Rifr recipient.  It will be especially interesting to see 
these effects with TraJ::VirD4WpΔ574 since transfer frequencies seems to be generally 
higher using this recipient and any effects should be more obvious. 
To reconcile these diverse findings, it is interesting that the CTE’s of the T4CPs 
under study varied in length and overall negative charge.  CTE’s with these physical 
properties could be important for binding of some substrates, but dispensable for binding of 
others. Also, it is important to note that, although the E. coli pKM101 system in general 
appears to be a useful surrogate for monitoring transfer of heterologous T4SS effectors, it 
also has several limitations.  E. coli is a different genetic context than A. tumefaciens, A. 
phagocytophilum or W. pipientis, and therefore might lack important adaptors or chaperones 
necessary for proper presentation of the effectors to the T4CP.  The absence of these 
auxiliary factors could affect how the CTE participates in substrate engagement.   
 Finally, it is remarkable that the VirD4Ap and VirD4Wp chimeric T4CP CTEs are very 
long (166 and 102 residues, respectively) and highly-negatively charged.  It is possible that 
the long CTEs adopt a structural fold within the T4CP that modulates the binding of some 
effector proteins that form charge-based contacts with the T4CP.  In this context, it is 
interesting that the VirD4Ap and VirD4Wp chimeras did not support transfer of the mobilizable 
IncQ plasmid.  Conceivably, the CTE’s of these proteins block engagement of the T4CP with 
DNA substrates by establishing charge-based interactions with a binding interface of the 
T4CP that alternatively could bind DNA.  If so, the CTE’s would essentially function as a 
DNA mimic.  In the natural A. phagocytophilum and W. pipientis hosts, the CTE’s might 
function as substrate specificity determinants by selectively blocking DNA translocation 
while promoting delivery of a repertoire of effector proteins into the mammalian cytosol to 
aid in infection.  
	  	   96	  
  
 
 
 
 
 
 
 
 
 
 
Chapter 6:  Summary and Perspectives 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  	   97	  
Summary 
 Type IV secretion systems are large complex machines, composed of a dynamic 
arrangement of 11 VirB proteins along with the coupling protein, VirD4 [1, 4].  These 
machines assemble across cell membranes to form an expansive secretion channel for the 
transport of macromolecules across the cell envelope and into the extracellular environment 
or other cells [1].  This thesis is focused on enhancing our understanding of substrate 
specificity and recruitment to the T4S channel, through interactions with the VirD4-like 
coupling proteins, and development of a chimeric translocation system.  I hypothesized that 
transfer of non-cognate effector substrates could be observed through a chimeric T4SS, and 
that the CTE of VirD4-like coupling proteins are functionally important for the transfer of 
protein effectors. 
 In chapter 3, I demonstrated that, while the A. tumefaciens T4SS did not serve as an 
efficient chimeric system for transfer of A. tumefaciens effectors or the IncQ plasmid, 
homologous T4CPs seemed to be interacting with components of the T4SS, as indicated by 
a “poisoning” phenotype.  This was measured through a reduction of virulence and IncQ 
transfer when homologous VirD4 proteins were produced in a wild-type strain, which also 
produced the native coupling protein.  While we were unable to confirm expression of the 
homologous coupling proteins, this experiment provided evidence that the proteins were 
produced in sufficient amounts to cause a disruption in substrate transfer.   
Functional analysis of the CTE of VirD4At in A. tumefaciens implied that the CTE 
plays a critical role in the transfer of some substrates required for plant virulence, but was 
dispensable for the RSF1010 derived IncQ plasmid, pML122.  This is comparable to a 
previous study that showed the TraD coupling protein, from the F-plasmid, carries a CTE 
that is required for F-transfer but inhibitory for RSF1010 transfer [12].  Taken together with 
the later evidence provided in chapter 5, showing variable effects of CTE deletion on 
chimeric T4CPs, it appears that the CTE may have an operative role in transfer of the 
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conjugative Ti-plasmid and a possible modulatory role in transfer of protein effectors.  Given 
the variable effects observed with deletion of the CTE on effector transfer, further studies 
are needed to elucidate the exact function of the CTE in protein transfer and any important 
residues, motifs, or structural folds required for interaction. 
Chapter 4 examines the capacity of the Tra T4SS, encoded on the E. coli plasmid 
pKM101, to serve as a surrogate system for translocating heterologous substrates.  Here I 
presented data identifying the IncQ plasmid, pML122, as a novel substrate, in addition to 
protein substrates from A. tumefaciens and Rickettsial homologs.  Cre recombinase based 
assays have been widely used for demonstrating transfer of effectors through a T4SS [20, 
25, 33].  In this study, I used the Cre-recombinase Reporter Assay for Translocation 
(CRAfT) to demonstrate that pKM101 could effectively translocate Cre-effector fusion 
proteins into a recipient cell.  This was very surprising, as pKM101 had not been examined 
for the ability to transfer effector proteins previously. Additionally, I confirmed these proteins 
were being transferred in a manner contingent on the presence of TraJ, as a ΔtraJ mutant 
showed undetectable transfer of all protein substrates.  Interestingly, presumed 
overexpression of traJ caused variable increases in transfer of several proteins, especially 
the putative Wolbachia effector WD0830 whose expression was undetectable on western 
blot.  However, use of an improved recipient strain, CHS26Cm::LTL,rifr(pUC4K), showed 
less variation in transfer levels. 
Also in chapter 4, I examined the use of heterologous T4CPs and a chimeric T4SS in 
E. coli.  As opposed to previous studies indicating T4CPs are able to interact productively 
with non-cognate Mpf proteins [9] or effector proteins[22], I was unable to show functional 
substitution of heterologous T4CPs for TraJ in mediating DNA transfer, nor did any of the 
heterologous T4CPs produce a “poisoning” phenotype in a wild-type pKM101 background.  
Additionally, most of the T4CPs tested were unable to functionally substitute for TraJ in 
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mediating protein transfer, with the exception of VirD4Ap, which was able to transfer Ats-1 at 
levels similar to those of strains producing TraJ. 
In Chapter 5 I focused on trying to enhance substrate transfer through the use of 
chimeric coupling proteins, containing the TMD of TraJ and the SD of the different VirD4 
homologs [9].  These chimeric coupling proteins were designed based on bioinformatic 
examination of homology between the protein sequences.  Therefore, it is possible that the 
junction points identified may not be optimal for these chimeras. Further bioinformatics 
analysis and experimentation are necessary to determine the ideal junctures for these 
chimeric proteins, conceivably resulting in more robust transfer. 
Based on the data presented, I was able to establish that the TraJ::VirD4At chimera is 
functional for IncQ and VirF substrate transfer, at frequencies of ~10-4 Tc’s/D and ~10-8 
Rc’s/D, respectfully.  Additionally, I tested several domain deletions of TraJ and the 
TraJ::VirD4At chimera, prepared by Dr. N. Whitaker, to assess the contributions of the AAD 
in substrate transfer, and found that the AAD was required for transfer of both pKM101 and 
IncQ.  This supports a model that the AAD is involved with the processing of substrates for 
transfer [11].  Furthermore, I determined that chimeras made with the VirD4Ap and VirD4Wp 
soluble domains were similarly functional for protein translocation, although neither proved 
functional for DNA substrate transfer. 
Finally, I developed C-terminal deletions in the chimeric T4CPs presented above, to 
assess the functional role of the CTE in substrate transfer.  While the CTE deletion of 
TraJ::VirD4At indicated an inhibitory role for the transfer of VirF, similar to Ats-1 with the CTE 
deletion of TraJ::VirD4Ap, the CTE of TraJ::VirD4Ap appears to be required for transfer of 
Aph_0111.  Similarly, previous studies have indicated the CTE of TraD provides increased 
specificity and efficiency with regards to F-plasmid transfer [72]. Furthermore, deletion of the 
CTE from TraJ::VirD4Wp had no effect on transfer of WD0811, indicating this effector is likely 
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interacting with another region within the VirD4Wp SD.  This assortment of results suggests 
the CTE may play a modulatory role for the transfer of some, but not all, effector proteins. 
The studies presented here were aimed at establishing a ‘proof-of-principle’ for the 
use of surrogate or chimeric T4SS’s to identify novel Rickettsial effectors, and to refine our 
knowledge of the molecular basis underlying the VirD4 receptor – substrate docking 
reaction.  Based on the data presented in this thesis, I was able to demonstrate that wild-
type pKM101 serves as an adequate surrogate T4SS for transport of non-cognate protein 
effectors.  Additionally, I determined that a chimeric T4SS in pKM101 was achievable 
through the use of chimeric coupling proteins. Lastly, I provided additional evidence that the 
CTE of VirD4-like proteins are functionally relevant for transfer of substrates.  However, the 
functionality of this domain appears to be T4CP and substrate specific.   
 
Comparison of effector translocation through the native and chimeric pKM101 
systems 
 Surrogate T4SSs are currently being used in A. tumefaciens and Legionella 
pneumophila to identify novel effector substrates from intracellular pathogens known to 
produce a T4SS [20-22].  However, these systems are complicated by prolonged growth 
cycles and, in the case of L. pneumophila, requirements of intracellular growth.  In this 
study, I presented data showing the native pKM101 system serves as a suitable surrogate 
for translocation of effector proteins from three different bacteria with frequencies of transfer 
ranging from ~10-6 to 10-8 Rc’s/D.  Furthermore, presumable overexpression of the T4CP, 
TraJ, from the multicopy plasmid pBAD24-Kanr enhances this transfer to nearly 10-4 Rc’s/D 
in some cases. 
 In an effort to improve efficiency of this system, chimeric T4CPs were produced 
along with the pKM101ΔtraJ T4SS.  While I did not achieve the enhanced efficiency I had 
hypothesized, I demonstrated that chimeric T4SSs were functional for protein translocation 
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and, in some cases, DNA transfer.  Additionally, the results obtained with chimeric T4CPs 
strongly suggest that the trans-membrane domain of the T4CP is necessary and sufficient 
for interacting with the rest of the translocation channel.  This is in agreement with previous 
studies that suggest the TMD interacts with the VirB10-like protein of the secretion channel 
[9] and the secretion channel as a whole [74].  The use of these chimeric coupling proteins 
in the pKM101 T4SS will allow further investigation into the roles of the AAD and CTE in 
substrate transfer, as well as identification of the interacting channel subunit. 
 
Future experiments 
 Experiments in the future should be centered on optimizing the efficiency of the 
heterologous or chimeric T4SS.  This would include i) reducing background transfer of Cre 
only and, ii) determining the optimal junctions for chimeric proteins.  Through use of the 
improved CRAfT recipient CHS26Cm::LTL,rifr(pUC4K), I have already eliminated 
non-specific background, which might have given rise to aberrantly high frequencies of Cre 
translocation and translocation efficiencies of other substrates.  Members of the Christie lab 
are continuing to test the native pKM101 system and the pKM101 T4SS producing chimeric 
T4CPs.  Additionally, two unanswered questions are being explored: i) What motifs and/or 
residues of the T4CP are required for substrate transfer, and ii) what is the role of the CTE 
in effector translocation? 
 
What motifs and/or residues of the T4CP are required for substrate transfer? 
 To further advance our understanding of the coupling protein – substrate interaction, 
and perhaps to help build a more effective chimeric T4SS, it would be beneficial to identify 
the exact binding interfaces.  The data present in this thesis indicates this interaction is 
substrate specific.  That is, different substrates appear to be dependent on different domains 
of the T4CP for transfer.  For example, in A. tumefaciens, presence of the VirD4At CTE is 
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required for the transfer of the Ti-plasmid and/or effector proteins, but is entirely dispensable 
for IncQ transfer.   
 To test for specific contacts between the T4CP and DNA or protein substrates, I 
propose using co-immunoprecipitation (Co-IP) and cross-linking studies as well as a two-
hybrid system designed for testing interactions within specific protein domains.  The goal of 
these Co-IP studies is to isolate complexes of T4CP domains with the substrate.  Chemical 
cross-linking would be used to stabilize any transient or otherwise weak interfaces.  
Additional Co-IP with mutant T4CPs deleted of specific domains or motifs, or containing 
amino acid substitutions, would further confirm the results by demonstrating a lack of 
interaction. 
 A potential issue with this proposed line of work is that VirD4-like coupling proteins 
form homohexamers in a working T4SS [11, 13].  It is likely that this structure is required for 
interaction, and any deletion or other alteration that disrupts hexamer formation could give 
false data.  Additionally, the use of T4CP fragments in Co-IP would not exhibit this hexamer 
formation and may not interact with substrates.  Therefore, another possible study would 
use bioinformatic analysis to identify potential interacting interfaces on the coupling protein 
and introduce a series of cysteine mutations to complete cross-linking studies with the 
substrate.  This has the added benefit of ascertaining the specific residues required for 
interaction and translocation of substrates. 
 
How is the CTE contributing to substrate secretion? 
 The data in this thesis, as well as other studies, have identified the C-terminal 
extension on some coupling proteins as playing a functional role in substrate secretion [72, 
74]. Additionally, we know that the CTE is not necessarily required, as several T4CPs 
function adequately without the presence of this domain (e.g. TraJpKM101 and TrwBF) [74].  
The studies presented here indicate that, when present, the CTE can act to either enhance 
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or inhibit transfer of both DNA and protein substrates.  Furthermore, this interaction between 
the substrate and the CTE of the T4CP seems to be very substrate specific.   
 In order to facilitate the study of the CTE and its contribution to substrate secretion, I 
propose making a series of GST fusions with CTEs from several different coupling proteins.  
I would then use these to perform a GST pull-down with cell lysates to isolate any interacting 
substrates, followed by analysis with SDS-PAGE and eventually mass spectrometry.  This 
kind of study would also help to identify if there is a particular motif that the CTE requires for 
interaction, which would be useful for in silico identification of potential substrates. 
 This project arose due to interest from those in the Rickettsial field in finding a 
surrogate system to confirm that candidate effectors are being translocated through a T4SS.  
To that end, I was able to demonstrate that the native pKM101 T4SS is adequate for 
translocation of a diverse set of substrates from a variety of bacterial species.  Additionally, 
the chimeric T4CPs generated provide an additional tool for demonstrating translocation as 
well as providing further insight into specific T4CP/substrate interactions.  The findings 
presented in this thesis should generate great interest from the Rickettsial field and lead to 
much fruitful collaboration between the Christie lab and Rickettsial labs. 
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